+ Site Statistics

References:

Abstracts:

29,560,870

PMIDs:

28,072,757

+ Search Articles

+ PDF Full Text Service

How our service works

Request PDF Full Text

+ Follow Us

Follow on Facebook

Follow on Twitter

Follow on LinkedIn

+ Subscribe to Site Feeds

+ Translate

+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 48279

Chapter 48279 contains a list of PDF Full Texts available from EurekaMag.

Find on this page:

Nandakumar, K.Selva.; Holmdahl, R., 2007:

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis

Dressler, D., 2003:

Antibody-induced failure of botulinum toxin therapy

Lee, S-Keun., 2007:

Antibody-induced failure of botulinum toxin type A therapy in a patient with masseteric hypertrophy

Du, Y.; Honeychurch, J.; Cragg, M.S.; Bayne, M.; Glennie, M.J.; Johnson, P.W.M.; Illidge, T.M., 2003:

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy

Sachs, U.J.H.; Hattar, K.; Weissmann, N.; Bohle, R.M.; Weiss, T.; Sibelius, U.; Bux, J., 2005:

Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model

Peng, K.Jun.; Huang, Y.Shan.; Han, X.Qun.; An, L.Na.; Zhang, J.Ge.; Wang, Q.Lin.; Wang, S.Ren., 2007:

Antibody-induced ozone production and its potential effects on pathogenesis of atherosclerosis

Graca, L.; Le Moine, A.; Cobbold, S.P.; Waldmann, H., 2004:

Antibody-induced transplantation tolerance: the role of dominant regulation

Renton, P.H.; Hancock, J.A., 1957:

Antibody-like effects of colloidal silica

Tozzi, C.; Giraudi, G., 2006:

Antibody-like peptides as a novel purification tool for drugs design

Celada, F.; Ellis, J.; Bodlund, K.; Rotman, B., 1971:

Antibody-mediated activation of a defective beta-D-galactosidase. II. Immunological relationship between the normal and the defective enzyme

Roos, A.; Garred, P.; Wildenberg, M.E.; Lynch, N.J.; Munoz, J.R.; Zuiverloon, T.C.M.; Bouwman, L.H.; Schlagwein, N.; Fallaux van den Houten, F.C.; Faber-Krol, M.C.; Madsen, H.O.; Schwaeble, W.J.; Matsushita, M.; Fujita, T.; Daha, M.R., 2004:

Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency

Trachsel, E.; Bootz, F.; Silacci, M.; Kaspar, M.; Kosmehl, H.; Neri, D., 2007:

Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis

Vincent, A., 2005:

Antibody-mediated disorders of neuromuscular transmission

Clark, T.G.; Dickerson, H.W., 2004:

Antibody-mediated effects on parasite behavior: Evidence of a novel mechanism of immunity against a parasitic protist

Rand, J.H.; Wu, X-Xuan., 2004:

Antibody-mediated interference with annexins in the antiphospholipid syndrome

Millen, S.H.; Bernstein, D.I.; Connelly, B.; Ward, J.I.; Chang, S-Ju.; Weiss, A.A., 2003:

Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells

Magliani, W.; Conti, S.; Arseni, S.; Salati, A.; Ravanetti, L.; Maffei, D.L.; Giovati, L.; Polonelli, L., 2006:

Antibody-mediated protective immunity in fungal infections

Jacob, A.; Sandhu, K.; Nicholas, J.; Jones, H.; Odum, J.; Rylance, P.; Carmichael, P.; Jackson, M.; Handa, S.; Macwhannell, A.; Basu, S.; Wahid, F.; Casadevall, N.; Mufti, G.; Macdougall, I., 2006:

Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent

Racusen, L.C.; Colvin, R.B.; Solez, K.; Mihatsch, M.J.; Halloran, P.F.; Campbell, P.M.; Cecka, M.J.; Cosyns, J-Pierre.; Demetris, A.J.; Fishbein, M.C.; Fogo, A.; Furness, P.; Gibson, I.W.; Glotz, D.; Hayry, P.; Hunsickern, L.; Kashgarian, M.; Kerman, R.; Magil, A.J.; Montgomery, R.; Morozumi, K.; Nickeleit, V.; Randhawa, P.; Regele, H.; Seron, D.; Seshan, S.; Sund, S.; Trpkov, K., 2003:

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

Rodriguez, E.R.; Skojec, D.V.; Tan, C.D.; Zachary, A.A.; Kasper, E.K.; Conte, J.V.; Baldwin, W.M., 2005:

Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers

Melcher, M.L.; Olson, J.L.; Baxter-Lowe, L.A.; Stock, P.G.; Posselt, A.M., 2006:

Antibody-mediated rejection of a pancreas allograft

Ciric, B.; Van Keulen, V.; Paz Soldan, M.; Rodriguez, M.; Pease, L.R., 2003:

Antibody-mediated remyelination operates through mechanism independent of immunomodulation

Mertens, D., 2003:

Antibody-mediated thrombosis and pregnancy loss

Bux, Jürgen., 2006:

Antibody-mediated transfusion-related acute lung injury

Hirano, N.; Taira, H.; Sato, S.; Hashikawa, T.; Tohyama, K., 2006:

Antibody-mediated virus clearance from neurons of rats infected with hemagglutinating encephalomyelitis virus

Papermaster, B.W.; Bradley, S.G.; Watson, D.W.; Good, R.A., 1962 :

Antibody-producing capacity of adult chicken spleen cells in newly hatched chicks

Hirsch, H., 1956:

Antibody-stimulant therapy of seroresistant latent syphilis

Stebbing, J.; Gazzard, B.; Patterson, S.; Bower, M.; Perumal, D.; Nelson, M.; McMichael, A.; Ogg, G.; Epenetos, A.; Gotch, F.; Savage, P., 2003:

Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination

Boghaert, E.R.; Sridharan, L.; Armellino, D.C.; Khandke, K.M.; DiJoseph, J.F.; Kunz, A.; Dougher, M.M.; Jiang, F.; Kalyandrug, L.B.; Hamann, P.R.; Frost, P.; Damle, N.K., 2004:

Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts

van de Loosdrecht, A.A.; Huijgens, P.C.; Ossenkoppele, G.J., 2004:

Antibody-targeted therapy: a paradigm of innovative treatment strategies in indolent and aggressive B-cell non-Hodgkin lymphoma

Wasastjerna, G., 1956:

Antibody-transforming activity

Sehon, A.H.; Gordon, J.; Rose, B., 1957:

Antibodylike factor in serums of ragweed-sensitive individuals shown in vitro

Ruyters, L., 1962:

Antibotics in hepatic coma

Stillerman, M.; Bernstein, S.H.; Smith, M.L.; Gittelson, S.B.; Karelitz, S., 1960:

Antibotics in the treatment of betahemolytic streptococcal pharyngitis: factors influencing the results

Nürnberg, J-H.; Abdul-Khaliq, H.; Ewert, P.; Lange, P.E., 2003:

Antibradycardia pacing in patients with congenital heart disease: experience with automatic threshold determination and output regulation (Autocapture)

Raskin, N., 1955:

Antibrain antibodies in multiple sclerosis; study of the antibrain antibodies in the blood of multiple sclerosis patients by complement fixation tests

Harwin, S.M.; Paterson, P.Y., 1962:

Antibrain antibodies of the 19S gamma-globulin type in rats with allergic encephalomyelitis

Dorinson, S.M., 1954:

Antibrool mask for children with cerebral palsy

Sandri, S., 1959:

Antibrucellar antibodies in sparse pleural effusions and in the cerebrospinal fluid in Malta fever

Verdu, R., 1955:

Antibrucellar vaccinotherapy in a painful syndrome of the locomotor apparatus possibly entailing brucellosis

Criscuolo, E.; Pierangeli Vera, N.; Ceballos, A.; Bergagna, H.F.; Vacchiani, H., 1950:

Antibrucellin and its efficacy in the treatment of human brucellosis

CRISCUOLO, E.; RAMACCIOTTI, F.; SANTOLAZA, A.; de PAOLASSO, E.R.W., 1950:

Antibrucellin in the treatment of febrile brucellosis

Criscuolo, E.; Pierangeli Vera, N.; Ceballos Uriarte, A.M.; Vacchiani, H., 1950:

Antibrucellin in the treatment of human brucellosis

Criscuolo, E.; Ceballos Uriarte, A.M.; Pierangeli Vera, N.; Vacchiani, H., 1951:

Antibrucellina in the treatment of human brucellosis

Criscuolo, E.; Vera, N.P.; Ceballos, A.; Bergagna, H.F.; Vacchiani, H., 1951:

Antibrucelline and its efficacy in the therapy of human brucellosis

CRISCUOLO, E.; RAMACCIOTTI, F.; SANTOLAYA, A.; de PAOLASSO, E.R.W., 1951:

Antibrucelline in the treatment of febrile brucellosis. I

Kasymova, K.A.; Beklemishev, N.D.; Uzbekova, B.R., 1960:

Antibrucellosis vaccination of subjects with positive immunological reactions

Beenakker, C.W.J.; Schomerus, H., 2004:

Antibunched photons emitted by a quantum point contact out of equilibrium

Suire, A., 1960:

Antiburucella vaccinations by the B.112 living strain. Study and comparison of different methods on mice

Schiff, T.; Saletta, L.; Baker, R.A.; He, T.; Winston, J.Leslie., 2006:

Anticalculus efficacy and safety of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice

Porciani, P.Francesco.; Grandini, S.; Sapio, S., 2003:

Anticalculus efficacy of a chewing gum with polyphosphates in a twelve-week single-blind trial

Schlehuber, S.; Skerra, A., 2005:

Anticalins as an alternative to antibody technology

Schlehuber, S.; Skerra, A., 2005:

Anticalins in drug development

Hussey, L.M., 1963:

Anticancer Agents

Maisin, H., 1963:

Anticancer Chemotherapy and Radiosensitization

Rice, M.C.; Bockman, J., 2005:

Anticancer Drug Discovery and Development - SRI's Seventh Annual Summit

Hirsch, P., 1964:

Anticancer League of Israel. Smoking and Air Pollution as Causes of Bronchogenic Carcinoma

Cruickshank, A., 1964:

Anticancer League of Israel. the Cancer Control System in the United Kingdom

Sun, C.; Liu, X.; Chen, Y.; Liu, F., 2007:

Anticancer activities of trichostatin A on maligant lymphoid cells

Wu, S.; Guo, W.; Teraishi, F.; Pang, J.; Kaluarachchi, K.; Zhang, L.; Davis, J.; Dong, F.; Yan, B.; Fang, B., 2006:

Anticancer activity of 5-benzylidene-2-phenylimino-1, 3-thiazolidin-4-one (BPT) analogs

Prévost, Gégoire.P.; Lonchampt, M.O.; Holbeck, S.; Attoub, S.; Zaharevitz, D.; Alley, M.; Wright, J.; Brezak, M.C.; Coulomb, Hélène.; Savola, A.; Huchet, M.; Chaumeron, S.; Nguyen, Q-Dé.; Forgez, P.; Bruyneel, E.; Bracke, M.; Ferrandis, E.; Roubert, P.; Demarquay, Dèle.; Gespach, C.; Kasprzyk, P.G., 2006:

Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex

Zhang, Q.; Xiang, G-ya.; Long, N.; Lin, J-liang.; Zeng, F-bo., 2006:

Anticancer activity of N-(phenylacetyl) doxorubicin combined with folate-targeted PGA

Solyanik, G.I.; Fedorchuk, A.G.; Pyaskovskaya, O.N.; Dasyukevitch, O.I.; Khranovskaya, N.N.; Aksenov, G.N.; Sobetsky, V.V., 2005:

Anticancer activity of aconitine-containing herbal extract BC1

Dabrowska, K.; Opolski, A.; Wietrzyk, J.; Switala-Jelen, K.; Godlewska, J.; Boratynski, J.; Syper, D.; Weber-Dabrowska, B.; Gorski, A., 2005:

Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models

Sebti, S.M.; Hamilton, A.D., 2005:

Anticancer activity of farnesyltransferase and geranylgeranyltransferase I inhibitors: prospects for drug development

Burlage, H.M.; Mckenna, G.F.; Taylor, A., 1956:

Anticancer activity of plant extracts

Swiatek, P.; Malinka, Wław., 2005:

Anticancer activity of some isothiazolo[5,4-b]pyridine derivatives

Olsen, L.Stengelshøj.; Hjarnaa, P-Julia.Vig.; Latini, S.; Holm, P.Kaae.; Larsson, R.; Bramm, E.; Binderup, L.; Madsen, M.Winkel., 2004:

Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity

Ng, R.; Better, N.; Green, M.D., 2006:

Anticancer agents and cardiotoxicity

Mirandola, P.; Sponzilli, I.; Gobbi, G.; Marmiroli, S.; Rinaldi, L.; Binazzi, R.; Piccari, G.Giuliani.; Ramazzotti, G.; Gaboardi, G.Carlo.; Cocco, L.; Vitale, M., 2005:

Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins

Dennison, S.R.; Whittaker, M.; Harris, F.; Phoenix, D.A., 2006:

Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes

Meena, P.Dutt.; Kaushik, P.; Shukla, S.; Soni, A.Kumar.; Kumar, M.; Kumar, A., 2007:

Anticancer and antimutagenic properties of Acacia nilotica (Linn.) on 7,12-dimethylbenz(a)anthracene-induced skin papillomagenesis in Swiss albino mice

Villedieu, M.; Briand, M.; Duval, M.; Héron, J.F.; Gauduchon, P.; Poulain, L., 2007:

Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression

Kumar, A.; Samarth, R.M.; Yasmeen, S.; Sharma, A.; Sugahara, T.; Terado, T.; Kimura, H., 2005:

Anticancer and radioprotective potentials of Mentha piperita

Ross, J.S.; Gray, K.; Gray, G.S.; Worland, P.J.; Rolfe, M., 2003:

Anticancer antibodies

Abbatucci, J.S., 1963:

Anticancer chemotherapy with thio-tepa. Results obtained in 40 cases

Würdinger, T., 2007:

Anticancer coronaviruses

Li, C.Ka-Lei.; Sun, R.Wai-Yin.; Kui, S.Chi-Fai.; Zhu, N.; Che, C-Ming., 2006:

Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties

Gemma, A.; Li, C.; Sugiyama, Y.; Matsuda, K.; Seike, Y.; Kosaihira, S.; Minegishi, Y.; Noro, R.; Nara, M.; Seike, M.; Yoshimura, A.; Shionoya, A.; Kawakami, A.; Ogawa, N.; Uesaka, H.; Kudoh, S., 2006:

Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database

Conti, M.; Tazzari, V.; Baccini, C.; Pertici, G.; Serino, L.Pio.; De Giorgi, U., 2007:

Anticancer drug delivery with nanoparticles

Gardner, C.R., 2004:

Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism

Braña, M.F.; Sánchez-Migallón, A., 2006:

Anticancer drug discovery and pharmaceutical chemistry: a history

Foubister, V., 2003:

Anticancer drug shows promise against lupus

Isnard-Bagnis, C.; Moulin, B.; Launay-Vacher, V.; Izzedine, H.; Tostivint, I.; Deray, G., 2006:

Anticancer drug-induced nephrotoxicity

Oka, M.; Fukuda, M.; Soda, H., 2005:

Anticancer drugs and ABC transporters

Andrews, J.R.; Shafer, I.E., 1953:

Anticancer drugs and hormones as adjuvants to the radiation therapy of cancer

Debrix, I.; André, T.; Becker, A.; Lotz, J-Pierre.; Gligorov, J.; Boukari, Y.; Milleron, B.; Pene, Fçoise.; Flahault, A., 2004:

Anticancer drugs off label used of: what do the experts think about?

Anonymous, 2003:

Anticancer drugs. Delayed toxicity

Anonymous, 2003:

Anticancer drugs. Early toxicity

Michenot, F.; Debats, P.; Audeval, C., 2003:

Anticancer drugs. Immediate toxicity

Kawamata, J.; Fujita, H.; Ikegami, R., 1960:

Anticancer effect of actinomycinic acid

Chung, P-Sang.; Kim, H-Gyun.; Rhee, C-Ku.; Saxton, R.E. , 2003:

Anticancer effect of combined intratumor cisplatin injection and interstitial KTP laser therapy on xenografted squamous cell carcinoma

Sun, C.; Liu, X.; Chen, Y.; Liu, F., 2005:

Anticancer effect of curcumin on human B cell non-Hodgkin's lymphoma

Wang, J.; Li, Q.; Ivanochko, G.; Huang, Y., 2006:

Anticancer effect of extracts from a North American medicinal plant--wild sarsaparilla

Yuan, S-Lan.; Wang, X-Jie.; Wei, Y-Quan., 2003:

Anticancer effect of tanshinone and its mechanisms

Bouabdallah, I.; M'Barek, L.Ait.; Zyad, A.; Ramdani, A.; Zidane, I.; Melhaoui, A., 2006:

Anticancer effect of three pyrazole derivatives

Reddy, C.Damodar.; Patti, R.; Guttapalli, A.; Maris, J.M.; Yanamandra, N.; Rachamallu, A.; Sutton, L.N.; Phillips, P.C.; Posner, G.H., 2005:

Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma

Yu, Z-lan.; Liu, X-rong.; McCulloch, M.; Gao, J., 2005:

Anticancer effects of various fractions extracted from Dioscorea bulbifera on mice bearing HepA

Gao, X-lin.; Li, Q-li.; Peng, Z-lan.; Wang, H., 2005:

Anticancer efficacy of combining cytosine deaminase/5-fluorocytosine gene therapy and radiotherapy on cervical carcinoma

Hamuro, J., 2005:

Anticancer immunotherapy with perorally effective lentinan

Naito, T.; Yokogawa, T.; Kim, H-Sook.; Futagami, M.; Wataya, Y.; Matsuda, A.; Fukushima, M.; Kitade, Y.; Sasaki, T., 2003:

Anticancer mechanisms of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106)

Dauchy, F., 1961:

Anticancer medications

Wataya, Y.; Futagami, M.; Naito, T.; Uchikubo, Y.; Yokogawa, T.; Takenaka, K.; Kim, H.S.; Matsuda, A.; Fukushima, M.; Kitade, Y., 2003:

Anticancer molecular mechanism of 3'-ethynylcytidine (ECyd)

Boumendjel, Aène.; Baubichon-Cortay, Hélène.; Trompier, D.; Perrotton, T.; Di Pietro, A., 2005:

Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents

Rico-Avello, C., 1955:

Anticancer organization in France, Switzerland and Belgium

Agarwal, R.; Agarwal, C.; Ichikawa, H.; Singh, R.P.; Aggarwal, B.B., 2007:

Anticancer potential of silymarin: from bench to bed side

Sahasrabudhe, M.B.; Narurkar, M.V.; Kotnis, L.B.; Tilak, B.D.; Shah, L.C.; Gogte Ven, 1961:

Anticancer properties of thiodiglycollic acid

Huang, C-xin.; Yu, H.; Yang, G-gen.; Wang, Q-qing.; Li, D.; Ma, W-xue.; Shen, F-ping., 2006:

Anticancer therapeutic effect of SEA-linked and membrane-bound HSP70-expressed intestine-carcinoma vaccine

Ravindranath, M.H.; Muthugounder, S.; Presser, N.; Viswanathan, S., 2004:

Anticancer therapeutic potential of soy isoflavone, genistein

Broxterman, H.J.; Georgopapadakou, N.H., 2005:

Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations

Hu, W.; Kavanagh, J.J., 2003 :

Anticancer therapy targeting the apoptotic pathway

Tomao, F.; Miele, E.; Spinelli, G.P.; Tomao, S., 2007:

Anticancer treatment and fertility effects. Literature review

Nencioni, A.; Grüenbach, F.; Patrone, F.; Brossart, P., 2004:

Anticancer vaccination strategies

Schwartz, H.; Delgado, J.N., 1960:

Anticancer, antispasmodic, anticholinergic drugs named

Zuckermann, C., 1956:

Anticancerous chemotherapy

Pauli, A., 2005:

Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils

Levy, J.P., 1961:

Anticaner agents

Bespalov, V.G.; Aleksandrov, V.A.; Petrov, A.S., 2007:

Anticarcinogenic action of dietary supplement pheocarpin and its active component

Bigot, P., 1961:

Anticarcinogenic antibiotics

Li, X.; Guan, Y-song.; Zhou, X-ping.; Sun, L.; Liu, Y.; He, Q.; Fu, L.; Mao, Y-qiu., 2005:

Anticarcinogenic effect of 20(R)-ginsenoside Rg3 on induced hepatocellular carcinoma in rats

Banerjee, S.; Das, S., 2005:

Anticarcinogenic effects of an aqueous infusion of cloves on skin carcinogenesis

Anticarcinogenic potential of lipids from Hippophae--evidence from the recent literature

Atchaneeyasakul, L-Ongsri.; Trinavarat, A.; Bumrungsuk, P.; Wongsawad, W., 2005:

Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in thai patients

Tarkun, I.; Hacihanefioğlu, A.; Tarkun, P.; Cetinarslan, B.; Cantürk, Z., 2005:

Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus

Ranua, J.; Luoma, K.; Peltola, J.; Haapala, A.M.; Raitanen, J.; Auvinen, A.; Isojärvi, J., 2004:

Anticardiolipin and antinuclear antibodies in epilepsy--a population-based cross-sectional study

Lima Cabrita, F.Vieira.; Foster, C.Stephen., 2005:

Anticardiolipin antibodies and ocular disease

Lee, C-H.; Wang, I-K.; Chen, T-C.; Chang, H-W.; Yang, C-C.; Chien, Y-S.; Wu, C-S.; Chiou, T.T-Y.; Wu, M-S.; Wang, P-H.; Chuang, F-R., 2006:

Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: a retrospective study

Kahwa, E.K.; Sargeant, L.A.; McCaw-Binns, A.; McFarlane-Anderson, N.; Smikle, M.; Forrester, T.; Wilks, R., 2006:

Anticardiolipin antibodies in Jamaican primiparae

Elefsiniotis, I.S.; Diamantis, I.D.; Dourakis, S.P.; Kafiri, G.; Pantazis, K.; Mavrogiannis, C., 2003:

Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis

Yuste, Jé.R.; Prieto, Jús., 2003:

Anticardiolipin antibodies in chronic viral hepatitis. Do they have clinical consequences?

Calvo Romero, J.M., 2006:

Anticardiolipin antibodies in elderly patients with venous thromboembolic diseases in an area of the south of Extremadura (Spain)

Enzenauer, R.J.; Collier, D.H.; Lopez, L.R., 2006:

Anticardiolipin antibodies in scleroderma

Daboubi, M.K., 2003:

Anticardiolipin antibodies in women with recurrent abortion

Daif, A.K.; Jabbar, M.A.; Ogunniyi, A., 2007:

Anticardiolipin antibodies in young Saudis with ischemic stroke

Tănăsescu, R.; Ticmeanu, M.; Nicolau, A.; Uscătescu, V.; Cojocaru, M.; Grecu, V.; Serbănescu, A., 2006:

Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients

Kamada, H.; Suzuki, K., 2005:

Anticardiolipin antibody (aCL)

Chuang, F-R.; Chang, H-W.; Lin, C-L.; Wang, I-K.; Chang, H-Y.; Wang, P-H.; Yang, C-C.; Chen, T-C.; Wu, C-S.; Lee, C-H., 2005:

Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis

Vikoren, T.H.; Fenwick, J.A.; Cross, B.J.; Ragni, M.V.; Gruen, G.S., 2003:

Anticardiolipin antibody associated arterial thrombosis following fibula fracture

Kelishadi, R.; Sabet, B.; Khosravi, A., 2003:

Anticardiolipin antibody of adolescents and age of myocardial infarction in parents

Harris, E.Nigel.; Khamashta, M., 2004 :

Anticardiolipin test and the antiphospholipid (Hughes) syndrome: 20 years and counting!

Schreiber, H., 1953:

Anticaries effect of vitamin K

Fisher, S.W.; Tavss, E.A.; Gambogi, R.J.; Joziak, M., 2003:

Anticaries efficacy of a new dentifrice for hypersensitivity

Pfarrer, A.M.; McQueen, C.M.; Lawless, M.A.; Rapozo-Hilo, M.; Featherstone, J.D.B., 2006:

Anticaries potential of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice

Turian, G.; Schopfer, J.F., 1960:

Anticarotenogenic action of diphenylamine in the alga Chlorella rubescens

Anonymous, 1959:

Anticatabolic & anticalcinotic effects of 17-ethyl-19-nortestosterone

Burlina, A., 1958:

Anticatabolic activity of 4-chlorotestosterone acetate

Baticci, F.; Bozzetti, F., 1990:

Anticatabolic properties of branched chain amino-acids in post-operative patients. A prospective study

Klaus, D., 1953:

Anticatalase effect of the blood plasma

Galenko-Yaroshevskii, P.A.; Gurskaya, E.V.; Chikobava, E.A.; Sukoyan, G.V., 2004:

Anticataleptic effect of energostim during single treatment with trifluoperazine

Kleven, M.S.; Assié, M-Bernadette.; Cosi, C.; Barret-Grévoz, C.; Newman-Tancredi, A., 2004:

Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation

Gero, E., 1952:

Anticatalyzers of the oxidation of L-ascorbic acid: a new copper complex of thiamine

Gero, E., 1954:

Anticatalyzers of the oxidation of L-ascorbic acid: inhibiting action of folic acid

Siddiqui, T.A.; Shadab, Z.; Nishat, I.; Ayasha, N.; Zehra, Z.; Alavi, S.H., 2003:

Anticataract activity of Kohl-Chikni Dawa--a compound ophthalmic formulation of Unani medicine in alloxan-diabetic rats

Cajano, A.; Maurea, C., 1950:

Anticell and antiorgan sera; experimental research. II

Cajano, A.; Maurea, C., 1950:

Anticell and antiorgan sera; experimental research. III

Consoli, G.; Ricciardi, S.; Talarico, L.; Altucci, P., 1957:

Anticellular activity of alkyl sulfonates. III. Carcinostatic effect of 2-fluoroethyl methanesulfonate on Walker carcinoma, benzopyrene sarcoma, sarcoma 180 & myeloma of rat

Ricciardi, S.; Talarico, L.; Altucci, P.; Riccardi, C.; Consoli, G., 1958:

Anticellular activity of alkylsulfonates. IV. Effects on blood cells

Ricciardi, S.; Talarico, L.; Altucci, P.; Riccardi, C.; Consoli, G., 1958:

Anticellular activity of alkylsulfonates. V. Morphological and functional study of the bone marrow

Cajano, A.; Maurea, C.; Guarino, A., 1953:

Anticellular and antiorganic sera; experimental studies. VIII. Antihepatic serum; antihepatic heteroimmunization in guinea pig

Bergel, M., 1957:

Anticeroid activity of antimycobacterial agents

Lee, S.Houng.; Kwon, Y.; Kwon, Y., 2006:

Anticharmed pentaquark from B decays

Wiebe, E.R.; Trouton, K.J.; Fielding, S.L.; Klippenstein, J.; Henderson, A., 2005:

Antichoice attitudes to abortion in women presenting for medical abortions

Ivanoff, B.; Chaignat, C.L., 2003:

Anticholera vaccines and vaccination

Kharauzov, N.A., 1964:

Anticholesteremic Substances

Landmark, K.; Aursnes, I., 2003:

Anticholesteremic agents and omega-3 fatty acids

Girardet, J-Philippe., 2003:

Anticholesteremic agents in children

Annoni, G.; Longaretti, A., 1961:

Anticholesteremic and antilipemic effects of a non-estrogenic hexoestrol derivative known as coronary dilator

Angelucci, L.; Mascitelli, C.Riandoli, E., 1958:

Anticholesterol activity of alpha-lipoic acid

Longaretti, A., 1957:

Anticholesterolemic action of a synthetic choleretic drug (diethanolamino methyltoluylcarbinolcamphorate)

Meeroff, M., 1964 :

Anticholinergic Agents in Gastroenterology

Friend, D.G., 1964:

Anticholinergic Drugs

Meeroff, M., 1964:

Anticholinergic Drugs in Gastroenterology

Fedorov, V.V.; Ivanova, I.A.; Glukhov, A.V.; Reznik, A.V.; Rozenshtraukh, L.V.; Golitsyn, S.P.; Ruda, M.Ia.; Chazov, E.I., 2004:

Anticholinergic Effect of a New Antiarrhythmic Class III Drug RG-2

Buchel, L.; Levy, J., 1964:

Anticholinergic Properties of the Benzyl Ester of N-Diethyl-1,1-Hydroxypyrrolidium-3 Bromide (Benzilonium Bromide)

Manning, J.Sloan., 2004:

Anticholinergic Side Effects in Perspective

Bachmann, R., 1964:

Anticholinergic Therapy

Agarwal, S.L.; Arora, R.B., 1956:

Anticholinergic actions of chloroquine and camoquin on smooth and cardiac muscles

Corbett, C.E.; Limongi, J.P.; Ramos, A.O., 1957:

Anticholinergic activity of the ortho-carboxybenzeneseleninic acid

Westby, M.; Benson, M.; Gibson, P., 2004:

Anticholinergic agents for chronic asthma in adults

Spiess, J.L.; Scott, S.D., 2003:

Anticholinergic agents for the treatment of "death rattle" in patients with myasthenia gravis

Kanazawa, H., 2005:

Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling

Texter, E.C.; Barborka, C.J., 1954:

Anticholinergic agents in the treatment of peptic ulcer

Raveh, L.; Brandeis, R.; Gilat, E.; Cohen, G.; Alkalay, D.; Rabinovitz, I.; Sonego, H.; Weissman, B.Avi., 2003:

Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction

Legerton, C.W., 1959:

Anticholinergic anesthesia

Wills, J.H., 1961:

Anticholinergic compounds as a adjuncts to atropine in preventing lethality by Sarin in the rabbit

Kirsner, J.B., 1957:

Anticholinergic compounds in peptic ulcer

Madersbacher, H., 2006:

Anticholinergic drugs and CNS relevance for therapy

Doraiswamy, P.Murali.; Husain, M.M., 2006:

Anticholinergic drugs and elderly people: a no brainer?

BECK, I.T.; McKENNA, R.D., 1958:

Anticholinergic drugs as used in the management of peptic ulcer; their mechanism of action and their comparative value

Kripke, C., 2006:

Anticholinergic drugs for overactive bladder

Everard, M.L.; Bara, A.; Kurian, M.; Elliott, T.M.; Ducharme, F.; Mayowe, V., 2005:

Anticholinergic drugs for wheeze in children under the age of two years

McDONOUGH, F.E.; HAMMOND, J.B., 1954:

Anticholinergic drugs in gastrointestinal disease

Irani, J., 2006:

Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: Where do we stand in 2006?

Kirsner, J.B.; Ford, H.; Kassriel, R.S., 1957:

Anticholinergic drugs in peptic ulcer; their current status

Colli, F.; Barbieri, G.C., 1958:

Anticholinergic drugs in preanesthesia; hemodynamic findings in noncardiac patients

Stephen, C.R.; Bowers, M.A.; Nowill, W.K.; Martin, R.C., 1956:

Anticholinergic drugs in preanesthetic medication

Aste, G.; Lecannelier, S.; Biel, F.; Cerda, M., 1955:

Anticholinergic drugs in the motility of the human irritable colon

Bertolotto, R., 1957:

Anticholinergic drugs in therapy of infantile nocturnal enuresis; clinical study

Alhasso, A.A.; McKinlay, J.; Patrick, K.; Stewart, L., 2006:

Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults

Nabi, G.; Cody, J.D.; Ellis, G.; Herbison, P.; Hay-Smith, J., 2006:

Anticholinergic drugs versus placebo for overactive bladder syndrome in adults

Krejcová, G.; Kassa, Jí., 2004:

Anticholinergic drugs--functional antidotes for the treatment of tabun intoxication

Gurskaite, H.; Gendviliene, V.; Zablockaite, D.; Martisiene, I.; Stankevicius, A., 2006:

Anticholinergic effect of procainamide and its sulfonylcarbamide derivatives on electromechanical activity in guinea pig atrium

Pollock, B.G., 2004:

Anticholinergic effects in older adults. Weighing the risk-benefit ratio

Vojtechovsky, M.; Grof, S., 1961:

Anticholinergic hallucinogens in a model of delirium tremens

Thibeault, L.; Brisson, S., 2005:

Anticholinergic intoxication

Witte, F., 2006:

Anticholinergic medications can help impared cognitive performance

Ness, J.; Hoth, A.; Barnett, M.J.; Shorr, R.I.; Kaboli, P.J., 2006:

Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events

Kemper, R.F.; Steiner, V.; Hicks, B.; Pierce, L.; Iwuagwu, C., 2007:

Anticholinergic medications: use among older adults with memory problems

Gilani, S.Mushtaq.; Jamil, M.; Akbar, F.; Jehangir, R., 2006:

Anticholinergic premedication for prevention of oculocardiac reflex during squint surgery

Turrian, H.; Gross, F., 1958:

Anticholinergic properties of hypnotic and anticonvulsive glutarimides

Pauling, P.; Datta, N., 1980:

Anticholinergic substances: A single consistent conformation

Kemmerer, D.A., 2007:

Anticholinergic syndrome

Brown, D.V.; Heller, F.; Barkin, R., 2004:

Anticholinergic syndrome after anesthesia: a case report and review

Piccillo, G.A.; Miele, L.; Mondati, E.; Moro, P.A.; Musco, A.; Forgione, A.; Gasbarrini, G.; Grieco, A., 2006:

Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time

McDonald, N.J.; Bara, A.I., 2003:

Anticholinergic therapy for chronic asthma in children over two years of age

Baldauf, H.; Goehring, K., 1960:

Anticholinergic therapy of cerebrocranial injuries

Lechner, H., 1963:

Anticholinergic therapy of craniocerebral trauma

Ingelfinger, F.J., 1963:

Anticholinergic therapy of gastrointestinal disorders

Jenkner, F.L., 1957:

Anticholinergic therapy of severe closed brain trauma

Di Grande, A.; Paradiso, R.; Amico, S.; Fulco, G.; Fantauzza, B.; Noto, P., 2004:

Anticholinergic toxicity associated with lupin seed ingestion: case report

Litkey, J.; Dailey, M.W., 2007:

Anticholinergic toxicity associated with the ingestion of lupini beans

Jenkner, F.L., 1955:

Anticholinergic treatment of closed brain trauma

Jenkner, F.L.; Lechner, H., 1955:

Anticholinergic treatment of closed cranial and brain injuries

Nasio, J., 1960:

Anticholinergic treatment of gastroduodenal ulcer

Favier, G.; Vague, J., 1956:

Anticholinergic treatment of gastroduodenal ulcer; its application with the use of propantheline

Møller, L.Alling.; Lose, G., 2003:

Anticholinergic treatment of overactive bladder. A costly treatment with doubtful clinical effect?

Smith, C.W.; Thomas, C.G., 1959:

Anticholinergic-ataractic therapy in functional and organic gastrointestinal disorders; a controlled evaluation

Rottini, E.; Marri, G.; Calandra, P., 1962:

Anticholinergic-meprobamate combination in the therapy of diseases of the digestive tract of psychosomatic nature

Gonzalez Campos, C., 1956:

Anticholinergics and peptic ulcer

Lima, A.R.; Weiser, K.V.S.; Bacaltchuk, J.; Barnes, T.R.E., 2004:

Anticholinergics for neuroleptic-induced acute akathisia

Rathbone, J.; Soares-Weiser, K., 2006:

Anticholinergics for neuroleptic-induced acute akathisia

Michel, M.C.; Barendrecht, M.M.; Oelke, M., 2006:

Anticholinergics for overactive bladder: does subtype selectivity play a role?

Katzenschlager, R.; Sampaio, C.; Costa, J.; Lees, A., 2003:

Anticholinergics for symptomatic management of Parkinson's disease

Friedman, J.H., 2006:

Anticholinergics in dementia and other confounding problems

Jinich, H., 1953:

Anticholinergics in gastroenterology

Wissmer, B., 1959:

Anticholinergics in the therapy of disorders of the digestive tract

See, S.; Geer, K., 2003:

Anticholinergics reduce symptoms of overactive bladder

Neafsey, P.J., 2004:

Anticholinergics: not such a dry topic anymore

Coleman, I.W.; Little, P.E.; Grant, G.A., 1959:

Anticholinestease antidotes. IV. The effectiveness of the induction of methaemoglobinemia as an adjunct to therapy for GA poisoning

Thomas, J.; Staniforth, D., 1964:

Anticholinesterase Activity and Charge Delocalisation in "aliphatic" and "aromatic" Quaternary Ammonium Compounds

Malatesta, P.; D Arca, S.U., 1964:

Anticholinesterase Activity of some Phosphoramide Esters

Iwatsuki, K., 1963:

Anticholinesterase Drugs

Levy, J., 1951:

Anticholinesterase action of some esters of diethylaminoethanol with spasmolytic action

Vargiu, L., 1957:

Anticholinesterase action of various curarizing derivatives of stilbene in vitro

Cavallito, C.J.; Sandy, P., 1959:

Anticholinesterase activities of some bis-quaternary ammonium salts

Tazieff-Depierre, F.; Martin, L., 1960:

Anticholinesterase activity (in vitro) of 1, 3-bis(3-dimethylaminophenoxy)-propane dimethiodide and its dicarbamic ester

Kagan, I.S.; Ivanova, Z.V., 1961:

Anticholinesterase activity and toxicity of the sulfoxide and sulfone of M-74

Valentinova, I.; Janok, J., 1958:

Anticholinesterase activity in vitro of certain 0,0-dialkyl-S-(N,N-dialkylthiocarbamyl)-dithiophosphates

Bruzzese, E.; Malatesta, P., 1962:

Anticholinesterase activity of methyl S-(2-diethylaminoethyl)-N,N-dimethylphosphoramide and its iodomethylate. Their comparison with the activity of isopropyl methylfluorophosphate (Sarin)

Brik, I.L.; Iakovlev, V.A., 1962:

Anticholinesterase activity of oxidation products of dithiophosphoric acid (M-74)

Sabine, J.C.; Hayes, F.N., 1952:

Anticholinesterase activity of tributyl phosphate

Cannava, A.; Cavalleri, L., 1950:

Anticholinesterase activity of vitamin K and action on smooth muscles

Golz, H.H., 1958:

Anticholinesterase activity; recognition and detection in the field and hospital

Greig, N.H.; Ruckle, J.; Comer, P.; Brownell, L.; Holloway, H.W.; Flanagan, D.R.; Canfield, C.J.; Burford, R.G., 2005:

Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects

Cannava, A.; Manca, P., 1961:

Anticholinesterase and procaine-esterase activity of the blood and tissues of various species

Mentis, M.J.; Delalot, D.; Naqvi, H.; Gordon, M.F.; Gudesblatt, M.; Edwards, C.; Donatelli, L.; Dhawan, V.; Eidelberg, D., 2005:

Anticholinesterase effect on motor kinematic measures and brain activation in Parkinson's disease

Hazard, R.; Cheymol, J.; Corteggiani, E., 1953:

Anticholinesterase effects and sensitizing action on acetylcholine of some synthetic curare drugs

Basova, N.E.; Rozengart, E.V., 2006:

Anticholinesterase efficiency of some tropolone alkaloids and their lumiderivatives

Zabrodskii, P.F.; Germanchuk, V.G.; Kirichuk, V.F.; Nodel', M.L.; Aredakov, A.N., 2003:

Anticholinesterase mechanism as a factor of immunotoxicity of various chemical compounds

Delga, J., 1957:

Anticholinesterase organophosphors

Polonovski, M.; Pelou, A.; Schmitt, H., 1952:

Anticholinesterase substances in the potentialization of the vascular effects of two phenoxyisopropylamines with nicotinic activity

Funke, A.; Bagot, J.; Depierre, F., 1954:

Anticholinesterase. I. Synthesis of diphenoxyalkanes with one or two free phenolic functions

Cozza, A., 1952:

Anticholinesterases as war weapons

Anonymous, 2004:

Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease

Modugno, V.; Cannata, F., 1957:

Anticholinesterases in anesthesiological practice

Hughes, A.; Coulter, F.; Gillespie, R.; Livingston, H.; Phillips, K.; Quinn, E.; Rimmer, E.; Smith, M.; Walker, A., 2003:

Anticholinesterases in the treatment of Alzheimer's dementia--the first year's experience in Argyll & Clyde

Gandía, L.; Alvarez, R.M.; Hernández-Guijo, J.M.; González-Rubio, J.M.; de Pascual, R.; Rojo, J.; Tapia, L., 2006:

Anticholinesterases in the treatment of Alzheimer's disease

Depierre, F.; Funke, A., 1954:

Anticholinesterases. II. Prostigmine analogue derivatives; effect of chemical structure on intensity and selectivity of antiacetylcholinesterasic action

Depierre, F.; Martin, L., 1958:

Anticholinesterases; protection in vitro by quaternary ammonium compounds

Casier, H.; De Vleeschhouwer, G.R., 1952:

Anticholinesteratic and pharmacological effects of the bromide of N-P-Chlorophenyl-methylcarbamate of M-Hydroxyphenyltrimethylammonium (NU 1250)

Buffet, C., 2003:

Anticipate a cirrhosis without a hepatic biopsy in patients with hemochromatosis

White, A., 2004:

Anticipate responses to change

Stearns, P.M., 2006:

Anticipated 2007 nursing legislation in Colorado

Stonier, T., 1963:

Anticipated Biological and Environmental Effects of Detonating a Twenty- Megation Weapon on Columbus Circle in new York City

Keutzer, A., 1963:

Anticipated Development of Extrapulmonary Tuberculosis

Martinek, L.; Oberascher-Holzinger, K.; Weishuhn, S.; Klimesch, W.; Kerschbaum, H.H., 2004:

Anticipated academic examinations induce distinct cortisol responses in adolescent pupils

Fitzpatrick, T.R.; Vinick, B.H.; Bushfield, S., 2005:

Anticipated and experienced changes in activities after husbands retire

Schramm, W.; Danielson, W., 1958:

Anticipated audiences as determinants of recall

Hardy, W.G.; Lindner, D.W.; Thomas, L.M.; Gurdjian, E.S., 1962:

Anticipated clinical course in carotid artery occlusion

Rietveld, E.; De Jonge, H.C.C.; Polder, J.J.; Vergouwe, Y.; Veeze, H.J.; Moll, Hëtte.A.; Steyerberg, E.W., 2004:

Anticipated costs of hospitalization for respiratory syncytial virus infection in young children at risk

Caillot, J-Louis.; Paparel, P.; Arnal, E.; Schreiber, V.; Voiglio, E.J., 2005:

Anticipated detection of imminent surgeon-patient barrier breaches. A prospective randomized controlled trial using an indicator underglove system

Whiteman, M., 1957:

Anticipated frustration as a determinant of anxiety

Elton, N.W., 1952:

Anticipated progress of sylvan yellow fever in Nicaragua: plan for attempt to block its course in Honduras

Kostur, M.; Hänggi, P.; Talkner, P.; Mateos, Jé.L., 2005:

Anticipated synchronization in coupled inertial ratchets with time-delayed feedback: a numerical study

Calvo, O.; Chialvo, D.R.; Eguíluz, V.M.; Mirasso, C.; Toral, Rúl., 2004:

Anticipated synchronization: a metaphorical linear view

Kasparian, N.A.; Meiser, B.; Butow, P.N.; Soames Job, R.F.; Mann, G.J., 2006:

Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study

Willis, K.D., 2006:

Anticipating a Vioxx defense strategy: will corporate honesty be enough?

Herndon, C.M.; Kalauokalani, D.A.K.; Cunningham, A.J.; Jackson, K.C.; Dunteman, E.D., 2003:

Anticipating and treating opioid-associated adverse effects

Finlayson, G.S.; Stewart, D.; Tate, R.B.; MacWilliam, L.; Roos, N., 2005:

Anticipating change: how many acute care hospital beds will Manitoba regions need in 2020?

Azam, M.; Daley, G.Q., 2006:

Anticipating clinical resistance to target-directed agents : the BCR-ABL paradigm

Lynch, M.L.; Kodger, T.; Weaver, M.R., 2005:

Anticipating colloidal instabilities in cationic vesicle dispersions by measuring collective motions with dynamic light scattering

Hupert, N.; Wattson, D.; Cuomo, J.; Benson, S., 2006:

Anticipating demand for emergency health services due to medication-related adverse events after rapid mass prophylaxis campaigns

Nayar, M.; Miller, S., 2004:

Anticipating error: identifying weak links in the electronic healthcare environment

Berlot, G.; Pangher, A.; Petrucci, L.; Bussani, R.; Lucangelo, U., 2004:

Anticipating events of in-hospital cardiac arrest

Griffiths, P.D., 2006:

Anticipating full benefits from the new papillomavirus vaccines

Butler, L.D.; Field, N.P.; Busch, A.L.; Seplaki, J.E.; Hastings, T.Andrew.; Spiegel, D., 2004:

Anticipating loss and other temporal stressors predict traumatic stress symptoms among partners of metastatic/recurrent breast cancer patients

Andrus, J.Kim.; Tambini, G.; di Fabio, J.Luis.; Periago, M.Roses., 2005:

Anticipating new vaccines in the Americas

Branch, C.H.H., 1951:

Anticipating old age with assurance

Foley, M.Ann.; Foley, H.J.; Durley, J.R.; Maitner, A.T., 2007:

Anticipating partners' responses: examining item and source memory following interactive exchanges

Leo, F.; Venissac, N.; Pop, D.; Anziani, M.; Leon, M.E.; Mouroux, Jérôme., 2006:

Anticipating pulmonary complications after thoracotomy: the FLAM Score

Roth, S.H., 2006:

Anticipating rather than confirming drug toxicity through selective laboratory testing

Magnuson, H.J., 1960:

Anticipating safety and health needs

Abrahams, B.C.; Kaufman, D.M., 2004:

Anticipating smallpox and monkeypox outbreaks: complications of the smallpox vaccine

Mardis, E.R., 2007:

Anticipating the 1,000 dollar genome

Ribes-Iñesta, E.; Rodríguez, Mía.Elena.; Fuentes, M.Teresa., 2004:

Anticipating the correct matching response in a second-order matching-to-sample task

David, O.D., 1962:

Anticipating the future for students and teachers in nursing

Lipsy, R.J.; Fuller, M.G.; Roski, J.; Mansukani, S., 2004:

Anticipating the future: how the emergence of innovative biologic agents impacts benefit design, utilization, and provider relations

Ciszak, M.; Calvo, O.; Masoller, C.; Mirasso, C.R.; Toral, R., 2003:

Anticipating the response of excitable systems driven by random forcing

Hamon-Mekki, Fçoise., 2003:

Anticipating the unexpected in travel

Lowe, T.J., 2003:

Anticipating the worst is a good thing

Wicha, N.Y.Y.; Moreno, E.M.; Kutas, M., 2004:

Anticipating words and their gender: an event-related brain potential study of semantic integration, gender expectancy, and gender agreement in Spanish sentence reading

Pirmohamed, M., 2005:

Anticipating, investigating and managing the adverse effects of drugs

Ferner, R.E.; Coleman, J., 2005:

Anticipating, preventing and investigating medication errors

Sutter, J.M., 1956:

George, C., 1964:

Anticipation in the Resolution of a Complex Task

Fortune, M.Teresa.; Kennedy, J.L.; Vincent, J.B., 2003:

Anticipation and CAG*CTG repeat expansion in schizophrenia and bipolar affective disorder

Priest, W.S., 1957:

Anticipation and management of cardiac decompensation

Morris, C.G.; McBrien, M.E.; Farling, P.A., 2004:

Anticipation and planning for anaesthesia provision within MR units in the UK

Mccall, J.O., 1956 :

Anticipation and prevention of prolonged labor

Briquet Junior, R., 1952:

Anticipation and progressive heredity

Al-Essa, M.; Dabbagh, O.; Ozand, P.T., 2007:

Anticipation in a family with autosomal dominant spinocerebellar ataxia

Alexandrescu, D.T.; Garino, A.; Brown-Balem, K.A.; Wiernik, P.H., 2006:

Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree

Jønsson, V.; Johannesen, T.B., 2006:

Anticipation in lymphoproliferative disorders

Mello, R.G.T.; Oliveira, L.F.; Nadal, J., 2006:

Anticipation mechanism in body sway control and effect of muscle fatigue

Gamain, B., 1959:

Anticipation of acute respiratory insufficiency in the early sequels of pleuropulmonary surgery

Cocco, E.; Sardu, C.; Lai, M.; Spinicci, G.; Contu, P.; Marrosu, M.G., 2004:

Anticipation of age at onset in multiple sclerosis: a Sardinian cohort study

Hill, L.B., 1951:

Anticipation of arousing specific neurotic feelings in the psychoanalyst

Arden, G.B.; Friedmann, A.; Kolb, H., 1962:

Anticipation of chloroquine retinopathy

De Clercq, W.; Lemmerling, P.; Van Huffel, S.; Van Paesschen, W., 2003:

Anticipation of epileptic seizures from standard EEG recordings

De Clercq, W.; Lemmerling, P.; Van Huffel, S.; Van Paesschen, W., 2003:

Anticipation of epileptic seizures from standard EEG recordings

Branger, B., 2003:

Anticipation of hospital admission for pediatric bronchiolitis and gastroenteritis

Huang, Y.; Hayes, M.; Harding, A.J.; Brooks, W.S.; Fung, V.S.C.; Rowe, D.; Joffe, R.; Crimmins, D.; Hely, M.; Halliday, G.M., 2006:

Anticipation of onset age in familial Parkinson's disease without SCA gene mutations

Castro, G., 1957:

Anticipation of orchitis due to epidemic parotitis

Bergler, E., 1955:

Anticipation of punishment under the disguise of "senseless involuntary actions"

Jackson, R.C.; Warren, S.; Abernethy, B., 2006:

Anticipation skill and susceptibility to deceptive movement

Stieglitz, E.J., 1954:

Anticipation: a therapeutic objective

Vuoria, P., 2004:

Anticipations: risk of bias in cluster randomized trials

Saufley, W.H.; Bilodeau, I.M., 1964:

Anticipatory Rehearsal in Reversed Printing

Fujiwara, K.; Toyama, H.; Kunita, K., 2003:

Anticipatory activation of postural muscles associated with bilateral arm flexion in subjects with different quiet standing positions

Friedman, W.A.; Jones, L.M.; Cramer, N.P.; Kwegyir-Afful, E.E.; Zeigler, H.Philip.; Keller, A., 2005:

Anticipatory activity of motor cortex in relation to rhythmic whisking

Carpenter, J.A., 1952:

Anticipatory behavior in the rat following frontal lesions

Tjaden, K., 2003:

Anticipatory coarticulation in multiple sclerosis and Parkinson's disease

Babiloni, C.; Brancucci, A.; Del Percio, C.; Capotosto, P.; Arendt-Nielsen, L.; Chen, A.C.N.; Rossini, P.Maria., 2006:

Anticipatory electroencephalography alpha rhythm predicts subjective perception of pain intensity

Tabata, H.; Miura, K.; Kawano, K., 2005:

Anticipatory gain modulation in preparation for smooth pursuit eye movements

Lewis, I.Daniels.; McBride, M., 2004:

Anticipatory grief and chronicity: Elders and families in racial/ethnic minority groups

Smith, S.Hines., 2005:

Anticipatory grief and psychological adjustment to grieving in middle-aged children

Gundry, C.H.; Hunter, T.G.; Kerr, R.A.; Hopkins, B.E., 1954:

Anticipatory guidance

Nolan, M.Ellen., 2004:

Anticipatory guidance for parents of Prader-Willi children

Gundry, C.H.; Hall, B.E.; Hunter, T.G., 1952:

Anticipatory guidance in child health centers

Barkin, S.L.; Scheindlin, B.; Brown, C.; Ip, E.; Finch, S.; Wasserman, R.C., 2005:

Anticipatory guidance topics: are more better?

Lekander, M.; Fürst, C.J.; Rotstein, S.; Blomgren, H.; Fredrikson, M., 1995:

Anticipatory immune changes in women treated with chemotherapy for ovarian cancer

Cartwright, D., 2004:

Anticipatory interpretations: addressing "cautionary tales" and the problem of premature termination

Rietdyk, S., 2005:

Anticipatory locomotor adjustments of the trail limb during surface accommodation

Aapro, M.S.; Molassiotis, A.; Olver, I., 2004:

Anticipatory nausea and vomiting

McRonald, F.E.; Fleisher, D.R., 2005:

Anticipatory nausea in cyclical vomiting

Backlar, P., 2003:

Anticipatory planning for research participants with psychotic disorders like schizophrenia

Mutsaarts, M.; Steenbergen, B.; Bekkering, H., 2005:

Anticipatory planning of movement sequences in hemiparetic cerebral palsy

Dickstein, R.; Shefi, S.; Marcovitz, E.; Villa, Y., 2004:

Anticipatory postural adjustment in selected trunk muscles in post stroke hemiparetic patients

Aruin, A.; Shiratori, T., 2003:

Anticipatory postural adjustments while sitting: the effects of different leg supports

Gavaghan, C., 2004:

Anticipatory refusals and the action of 'wrongful living'

Billig, M.; Kohn, R.; Levav, I., 2006:

Anticipatory stress in the population facing forced removal from the Gaza Strip

Adams, J.A.; Creamer, L.R., 1962:

Anticipatory timing of continuous and discrete responses

van Venrooij, W.J.; Hazes, J.M.; Visser, H., 2003:

Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis

Kirdaite, G.; Redaitiene, E.; Dadoniene, J.; Stropuviene, S., 2003:

Anticitrulline antibodies - new marker in rheumatoid arthritis diagnostics

Dutta, D.; Devi, S.Saravana.; Krishnamurthi, K.; Chakrabarti, T., 2007:

Anticlastogenic effect of redistilled cow's urine distillate in human peripheral lymphocytes challenged with manganese dioxide and hexavalent chromium

Llau, J.V.; De Andrés, J.; Gomar, C.; Gómez-Luque, A.; Hidalgo, F.; Torres, L.M., 2007:

Anticlotting drugs and regional anaesthetic and analgesic techniques: comparative update of the safety recommendations

Percesepe, E., 1956:

Anticoagulant 3-(1-phenyl-propyl)-4-hydroxycoumarin in the treatment of phlebothrombosis and thrombophlebitis

Quick, A.J., 1963:

Anticoagulant Action of Adenosine Triphosphate

Maki, M.; Kikuchi, I.; Murakami, A., 1964:

Anticoagulant Activity of Digest Products of Fibrinogen by Plasmin

Oyvin, I.A.; Baluda, V.P.; Shegel, S.M.; Tokarev, O.Y.; Venglinskaya, E.A.; Yagodkina, E.G., 1964:

Anticoagulant and Antiphlogistic Properties of Phlogodym (Neodymium Pyrocatechol Disulphonate)

Gueyffier, H., 1964:

Anticoagulant and Fibrinolytic Medication

Master, A.M.; Russek, H.I.; Wright, I., 1964:

Anticoagulant Drug Therapy in Acute Cornonary Thrombosis and Allied Conditions

Matsuoka, S.; Homma, T., 1964:

Anticoagulant Drug Therapy in Myocardial Infarct

Heully, F.; Reng, D.E.; Taillandier, M.; Meyer, D.; Simon, G., 1964:

Anticoagulant Medication and Alopecia

Castrobianchino, O.; Beovide, H.; Ghiggino, C., 1964:

Anticoagulant Medication in the Prolonged Therapy of Thromboembolic Disease

Searcy, R.L.; Foreman, J.A.; Myers, H.D.; Bergquist, L.M., 1963:

Anticoagulant Properties of Tetracyclines

Donner, L.; Heyrovsky, A., 1964:

Anticoagulant Properties of the Aortic Wall in Arteriosclerosis

Donner, L.; Heyrovsky, A., 1964:

Anticoagulant Properties of the Arterial Wall

Storm, O.; Terslev, E.; Gammelgaard, P.A., 1964:

Anticoagulant Prophylaxis at Shunt Operations in Infants and Children with the Tetralogy of Fallot

Borgstroem, S.; Greitz, T.; Van Der Linden, W.; Molin, J.; Rudics, I., 1965:

Anticoagulant Prophylaxis of Venous Thrombosis in Patients with Fractured Neck of the Femur; a Controlled Clinical Trial Using Venous Phlebography

Kushelevskii, B.P.; Iastrebova, L.P., 1965:

Anticoagulant Resistance in the Light of the Neurohumoral Regulation of the Coagulation and Anti-Coagulation Blood System

Duchesne, G., 1964:

Anticoagulant Solutions. Standardization Problems

Goossens, N., 1963:

Anticoagulant Therapy

Keller, J., 1965:

Anticoagulant Therapy even in Small Hospitals?

Richards, R.L., 1963:

Anticoagulant Therapy in Acute Myocardial Infarction

Mackay, R.P., 1964:

Anticoagulant Therapy in Cerebrovascular Disease

Johnson, R.; Gratton, J.D.; Phaneuf, G., 1964:

Anticoagulant Therapy in the Acute Phase of Myocardial Infarct. Study of 246 Cases

Pratt, G.H., 1965:

Anticoagulant Therapy in the Surgical Patient

Froment, R., 1964:

Anticoagulant Therapy of Cardiovascular Diseases of Ischemic Origin

Wright, I.S., 1963:

Anticoagulant Therapy of Cerebrovascular Disorders

Pugliese, F.; Silvestri, G., 1963:

Anticoagulant Therapy of Myocardial Infarct

Herrera, R.N.; Avellaneda, M.; Gareca, C.; Juarezpenalva, R., 1963:

Anticoagulant Therapy of the Cerebral Thromboembolisms

Basu, D.P.; Baksi, K.B., 1963:

Anticoagulant Therapy with Acenocoumarin

Vorster, K., 1964:

Anticoagulant Therapy with Coumarins Under Constant Blood Coagulation Control

Brest, A.N.; Bower, R.; Heider, C., 1964:

Anticoagulant Therapy--A Clinical Dilemma

Celander, D.R.; Celander, E.; Martin, C.G., 1964:

Anticoagulant Therapy--Boon or Bane?

Wright, I., 1963:

Anticoagulant Therapy-A Matter of Discrimination

Denicola, P., 1964:

Anticoagulant Therapy: Present Problems of Control and Therapeutic Conduct

Welti, J.J., 1964:

Anticoagulant Treatment

Stroemgren, L.S., 1964:

Anticoagulant Treatment in Acute Heart Infarct. the Importance of Sufficient Dosage for the Course of the Disease

Skinhoj, E., 1963:

Anticoagulant Treatment in Cerebral Thrombosis

Duclos, F., 1963:

Anticoagulant Treatment in Chronic Valvular Heart Disease

Stroemgren, L.S., 1964:

Anticoagulant Treatment of Acute Myocardial Infarction. the Importance of Adequate Dosage for the Course of the Disease

Irvine, R.F., 1964:

Anticoagulant Treatment of Ischemic Heart Disease

Eckstein, M.; Guminska, M., 1956:

Anticoagulant action of 1, 3-indandione naphthyl derivatives

Castro, C.M.; Grilli, H.; De Soldati, L., 1957:

Anticoagulant action of a dicoumarol derivative: sintrom

Casula, D., 1955:

Anticoagulant action of dried extract of Hirudo officinalis

Copley, A.L.; Steichele, D.; Spradau, M.; Thorley, R.S., 1959:

Anticoagulant action of fibrin surfaces on mammalian blood

De Soldati, L.; Castro, C.M., 1957:

Anticoagulant action of heparin by intramuscular & subcutaneous routes

Koestenberger, M.; Gallistl, S.; Cvirn, G.; Baier, K.; Leschnik, B.; Muntean, W., 2004:

Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination

Limongi, J.P., 1953:

Anticoagulant action of organic arsenicals: liberation of heparin by neoarsphenamine; preliminary study

Castegnaro, E., 1957:

Anticoagulant action of polylactose sulfate

Oleszkiewicz, L.; Pachecka, A., 1954:

Anticoagulant action of vitamin K antagonist

Masure, R.; Moriau, M., 1961:

Anticoagulant activity in vitro and in vivo of a gastric extract

Kuznetsova, T.A.; Besednova, N.N.; Mamaev, A.N.; Momot, A.P.; Shevchenko, N.M.; Zvyagintseva, T.N., 2004:

Anticoagulant activity of fucoidan from brown algae Fucus evanescens of the Okhotsk Sea

Kirk, J.E., 1959:

Anticoagulant activity of human arterial mucopolysaccharides

Drozd, N.N.; Bannikova, G.E.; Makarov, V.A.; Varlamov, V.P., 2007:

Anticoagulant activity of sulfated polysaccharides

Lal, M.B.; Chowdhury, N.K., 1950:

Anticoagulant activity of the Indian cattle leech

Neri Serneri, G.G.; Rossi Ferrini, P.L., 1961:

Anticoagulant activity of the human arterial wall and that of various animal species

Nutescu, E.A., 2007:

Anticoagulant agents are mainstay therapies in the prevention and treatment of arterial and venous thrombosis. Introduction

Miscall, L.; Nolan, R.B.; Gordon, A.; Miller, H.I., 1962:

Anticoagulant agents in the surgical treatment of mitral stenosis

van Veen, S.Q.; Cheung, C.W.; Meijers, J.C.M.; van Gulik, T.M.; Boermeester, M.A., 2006:

Anticoagulant and anti-inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis

Hinder, M.; Paccaly, A.; Frick, A.; Shukla, U.; Simcox, K.; Miller, B.; Gebauer, A., 2005:

Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, with tirofiban in healthy volunteers

Chevoya, L.; Housholder-Hughes, S., 2006:

Anticoagulant and antiplatelet medications

Wielders, S.J.H.; Bennaghmouch, A.; Reutelingsperger, C.P.M.; Bevers, E.M.; Lindhout, T., 2006:

Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists

Oates-Whitehead, R.M.; D'Angelo, A.; Mol, B., 2003:

Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery

Pinter, I.; Csergo, I.; Karady, I., 1957:

Anticoagulant and clearing effects of heparin in hyperlipemia

Piomelli, S.; Schettini, F., 1956:

Anticoagulant and fibrinolytic action of parenteral trypsin; experimental study

Lombardi, V.; Guidi, G.; Scardigli, G.; Zini, F., 1961:

Anticoagulant and fibrinolytic activities in vitro and in vivo of mucopolysaccharides of the aorta

Stura, L.; Cravarezza, F., 1955:

Anticoagulant and hemostatic therapy in obstetrics and gynecology. I. Phenylindanedione

Cravarezza, F.; Stura, L., 1955:

Anticoagulant and hemostatic therapy in obstetrics and gynecology: reptilase

Karp, H.R., 1961:

Anticoagulant and surgical treatment of patients with cerebral thrombosis: current status

Saurbier, B.; Bode, C., 2006:

Anticoagulant and thrombolytic agents in acute coronary syndrome

Tudoranu, G.; Foni, I.; Toporas, P.; Creteanu, G.; Pavelescu, C., 1950:

Anticoagulant chemicals

Lévesque, H.; Borg, J-Y., 2003:

Anticoagulant clinic: a tool for reducing bleeding complications of oral anticoagulant treatment

Fitzgerald, E.W., 1962:

Anticoagulant control in acute myocardial infarction

Vladimirov, V.I.A., 1952:

Anticoagulant dicoumarin and its practice significance

Butcher, H.R., 1960:

Anticoagulant drug therapy for thrombophlebitis in the lower extremities. An evaluation

Jouve, A.; Bourde, C., 1952:

Anticoagulant drugs and coronary thrombosis

Castro Bianchino, O. , 1958:

Anticoagulant drugs in arteriosclerosis

Dumas, A., 1952:

Anticoagulant drugs in certain forms of arterial hypertension

Poch, G.F., 1961:

Anticoagulant drugs in the treatment of ischemic or hemorrhagic cerebral infarcts

Barritt, D.W.; Jordan, S.C., 1960:

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

Bobek, V.; Boubelik, M.; Fiserová, A.; L'uptovcová, M.; Vannucci, L.; Kacprzak, G.; Kolodzej, J.; Majewski, A.M.; Hoffman, R.M., 2005:

Anticoagulant drugs increase natural killer cell activity in lung cancer

Kwaan, H.C.; Samama, M.M., 2004:

Anticoagulant drugs: an update

Pulitano, E.; Marinosci, A., 1951:

Anticoagulant effect and inhibitory effect on erythrocyte sedimentation of sodium benzoate

Bono, F.; Cortinovis, R., 1956:

Anticoagulant effect of 2-(4-bromo) phenyl-1, 3-indandione (fluidemin)

POLIAK, R.Ia., 1955:

Anticoagulant effect of 2-phenyl-1, 3-indandione

Dhananjaya, B.L.; Nataraju, A.; Rajesh, R.; Raghavendra Gowda, C.D.; Sharath, B.K.; Vishwanath, B.S.; D'Souza, C.J.M., 2006:

Anticoagulant effect of Naja naja venom 5'nucleotidase: demonstration through the use of novel specific inhibitor, vanillic acid

Bourgain, R., 1956 :

Anticoagulant effect of a lipoid extract of beef brain

Martin, L.; Bourgain, R.; Reuse, J., 1957:

Anticoagulant effect of beef brain lipoid extract; biometric study

Donzelot, E.; Kaufmann, H.; Nabil, H.; Gilbert, Y., 1951:

Anticoagulant effect of physiological serum in intravenous perfusion

Gieri, C.; Cocito, C., 1952:

Anticoagulant effect of sodium hexametaphosphate

Uhry, P.; Kaufmann, H., 1953:

Anticoagulant effect of sympatholytics

Quivy, D.; Bertrand, I., 1950:

Anticoagulant effect of urea

Rosti, P., 1954:

Anticoagulant effects of 3,3'-ethylidenebis(4-hydroxycoumarin); importance of the calcium sensitivity index for the evaluation of hypocoagulation prompted by bishydroxycomarin derivatives

Echave, D., 1954:

Anticoagulant effects of the latex of Ficus domestica L. on blood in vitro

Gasser, H., 1957:

Anticoagulant hemophiloid disease in pemphigus vulgaris; a pathological-anatomical contribution

Hafner, C.D.; Cranley, J.J.; Krause, R.J.; Strasser, E.S., 1962:

Anticoagulant ileus

Hollis, C.D.; Logue, R.B., 1954:

Anticoagulant in acute myocardial infarction

Millette, L.; Reynolds, R.M., 1962:

Anticoagulant intoxication and intestinal obstruction

Des Floris, R.L.; Richon, J., 1961:

Anticoagulant medication

Merz, W.R.; Bossart, H., 1962:

Anticoagulant medication and venous thrombosis

Mouquin, M.; Macrez, C.; Ricordeau, G., 1952:

Anticoagulant medication in cardiopathies

Lafon, J.L., 1951:

Anticoagulant medication in myocardial infarction

Olivier, C., 1955:

Anticoagulant medication in surgery

Korenyi, C.; Goldschmidt, L.; Whittier, J.R., 1962:

Anticoagulant medication in the aged

Truchet, P., 1953:

Anticoagulant medication in the prevention and treatment of venous thrombosis in surgery

Ulrich, P., 1950:

Anticoagulant medication, preventive and curative, in gynecological surgery

Leconte Des Floris, R.; Richon, J., 1960:

Anticoagulant medication. I. General remarks on anticoagulant medication. The coagulation system. Thrombosis--anticoagulants

Richon, J.; Leconte Des Floris, R., 1960:

Anticoagulant medication. II. Heparin and synthetic heparinoids

Richon, J.; Leconte Des Floris, R., 1960:

Anticoagulant medication. IV. Antivitamin K agents. 2. Coumarin related derivatives and analogs

Leconte Des Floris, R.; Richon, J., 1960:

Anticoagulant medication. IX. Pulmonary arterial thrombosis

Leconte Des Floris, R.; Richon, J., 1960:

Anticoagulant medication. V. Long-term anticoagulant treatment. Ambulatory anticoagulant treatment

Leconte Des Floris, R.; Richon, J., 1960:

Anticoagulant medication. VI. Fundamental ideas concerning anticoagulant medication

Leconte Des Floris, R.; Richon, J., 1960:

Anticoagulant medication. VII. Some errors to avoid and some difficulties to overcome

Leconte Des Floris, R.; Richon, J., 1960:

Anticoagulant medication. VIII. Venous thrombosis of the extremities

Leconte Des Floris, R.; Richon, J., 1960:

Anticoagulant medication. X. Thromboembolic manifestations of heart diseases. 1

Leconte Des Floris, R.; Richon, J., 1960:

Anticoagulant medication. XI. Thromboembolic manifestations of cardiopathies. Thromboses and emboli in mitral cardiopathies

Leconte Des Floris, R.; Richon, J., 1961:

Anticoagulant medication. XII. The thromboembolic manifestations of heart diseases. (3d). Myocardial infarct and angina pectoris

Leconte Des Floris, R.; Richon, J., 1962:

Anticoagulant medicine

Baker, T.; Chan, R.; Hill, F., 2005:

Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant

Valentini, S.B.; Luminari, M., 1957:

Anticoagulant power of the bile

Kanazirski, P.; Denchev, V.; Levcheva, V., 1961:

Anticoagulant prevention of postoperative thrombo-embolic complications

Leroux, M.; Jamain, B., 1956:

Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350

Bianchi, M.; Cravarezza, F., 1955:

Anticoagulant prophylaxis by marcumar in gynecology and obstetrics

Cecchetti, G.; Joo, L.; Capelli, F.; Panizzon, E., 1962:

Anticoagulant prophylaxis in cardiac catheterization

Douketis, J.D.; Rabbat, C.; Crowther, M.A., 2005:

Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency

Von Brandis, H.J., 1956:

Anticoagulant prophylaxis of thromboembolism in a medium-sized hospital

Malagamba, G., 1955:

Anticoagulant prophylaxis with marcoumar in the puerperium

Storm, O., 1958:

Anticoagulant protection in surgery

Fantl, P.; Sawers, R.J., 1956:

Anticoagulant specificity and physiologically inactive beta-prothromboplastin

Prior, I., 1957:

Anticoagulant studies with dicoumarol and marcoumar; control achieved and applications

Prior, I.A., 1955:

Anticoagulant studies with marcoumar, a new coumarin derivative

Cheymol, J., 1956:

Anticoagulant substances and anticurarimimetic action

Li Voti, P., 1951:

Anticoagulant substances in the blood and tissues in the pathogenesis of Buerger's disease

Jimenez Casado, M., 1954:

Anticoagulant therapeutics. I. Drugs of choice

Dainotto, F.; Tognazzi, D.; Violanti, A., 1961:

Anticoagulant therapy and Owren's thrombotest

Kwapis, B.W., 1963:

Anticoagulant therapy and dental practice

Zitterell, K.; Abourjaily, H.M.; Rosenberg, M., 2003:

Anticoagulant therapy and dentistry

Kinder, B.W.; Collard, H.R.; King, T.E., 2006:

Anticoagulant therapy and idiopathic pulmonary fibrosis

Donzelot, E.; Kaufmann, H., 1953:

Anticoagulant therapy and its indications in cardiovascular diseases

Lemire, Y., 1963:

Anticoagulant therapy and myocardial infarct

Cosgriff, S.W., 1953:

Anticoagulant therapy and prophylaxis

Pataro, V.F.; Mas, S., 1953:

Anticoagulant therapy and sympathetic nerve block; retroperitoneal hemorrhage; death

Ahuja, M.M., 1961:

Anticoagulant therapy and the associated risks

Thienes, C.H., 1952:

Anticoagulant therapy for ambulatory patients

Kubo, H., 2006:

Anticoagulant therapy for idiopathic pulmonary fibrosis

Karsay, G.; Koranyi, A., 1956:

Anticoagulant therapy in Paget-Schroetter syndrome

Mcgreevy, J.V.; Mcgreevy, E.J., 1953:

Anticoagulant therapy in acute arterial thrombosis

Marshall, J.; Shaw, D.A., 1960:

Anticoagulant therapy in acute cerebrovascular accidents. A controlled trial

Moia, B., 1956:

Anticoagulant therapy in acute cor pulmonale caused by pulmonary embolism

Laterre, P-François.; Wittebole, X.; Dhainaut, J-François., 2003:

Anticoagulant therapy in acute lung injury

Vanderveer, J.B., 1951:

Anticoagulant therapy in acute myocardia infarction, venous thrombosis and pulmonary embolism

Dailheu-Geoffroy, P., 1950:

Anticoagulant therapy in cardiac diseases

Manson, D.I.; Fullerton, H.W., 1956:

Anticoagulant therapy in cardiac infarction

Donzelot, E.; Kaufmann, H.; Nabil, H., 1951:

Anticoagulant therapy in cardiologic practice

Debenedetti, V.; Ravera, M., 1956:

Anticoagulant therapy in cardiovascular diseases

Adrio Mateo, J.A., 1951:

Anticoagulant therapy in cardiovascular processes

Vannas, S., 1962:

Anticoagulant therapy in central retinal vein occlusion

Fisher, C.M., 1961:

Anticoagulant therapy in cerebral thrombosis and cerebral embolism. A national cooperative study, interim report

Millikan, C.H.; Siekert, R.G.; Whisnant, J.P., 1958:

Anticoagulant therapy in cerebral vascular disease; current status

Shaw, D.A., 1962:

Anticoagulant therapy in cerebrovascular diseases

Anderson, G.M., 1957:

Anticoagulant therapy in coronary artery insufficiency

Keller, R., 1957:

Anticoagulant therapy in daily practice

Burton, C.R., 1955:

Anticoagulant therapy in fresh infarction of the heart

Foti, M., 1954:

Anticoagulant therapy in geriatric gynecology

Urdan, B.E.; Wagner, M., 1951:

Anticoagulant therapy in gynecologic surgery

Duff, I.F.; Linman, J.W., 1950:

Anticoagulant therapy in heart disease, with particular reference to its use in congestive failure

Marple, C.D., 1950:

Anticoagulant therapy in heart disease. A summary of the literature

Kian, K.; Eiger, G., 2003:

Anticoagulant therapy in hyperosmolar non-ketotic diabetic coma

Marks, J., 1956:

Anticoagulant therapy in idiopathic occlusion of the axillary vein

Funder, R.; Ugland, O.M., 1963:

Anticoagulant therapy in mammaplasty

Duff, I.F.; Falls, H.F.; Linman, J.W., 1951:

Anticoagulant therapy in occlusive vascular disease of the retina

Berkman, Z., 1956:

Anticoagulant therapy in otitic thrombophlebitis; report of six cases

Pulkkinen, K., 1962:

Anticoagulant therapy in otorhinolaryngology

Lombardi, V.; Scardigli, G.; Guidi, G., 1960:

Anticoagulant therapy in peripheral arteriopathies

Barker, N.W., 1951:

Anticoagulant therapy in peripheral vascular disease

Sirotkina, M.G., 1962:

Anticoagulant therapy in plastic surgery of the superior vena cava in experimental conditions

Onate, J., 1963:

Anticoagulant therapy in pulmonary thromboembolism

Dan, V.N.; Chupin, A.V.; Sapelkin, S.V.; Chikharev, M.V.; Pokrovskĭ, A.V., 2003:

Anticoagulant therapy in reconstructive surgery of femoro-popliteo-tibial segment

Somberg, J.S., 1953:

Anticoagulant therapy in retinal vessel occlusions

Hope-Stone, H.F.; Key, J.J., 1961:

Anticoagulant therapy in superior mediastinal obstruction

De Takats, G., 1950 :

Anticoagulant therapy in surgery

Antila, L.E., 1962:

Anticoagulant therapy in surgical disease

Tidrick, R.T., 1949:

Anticoagulant therapy in surgical patients

Craig, D.S., 1955:

Anticoagulant therapy in the domiciliary management of coronary thrombosis

Marple, C.D., 1951:

Anticoagulant therapy in the treatment of acute coronary occlusion with myocardial infarction

Greenstein, J.; Turner, H.E., 1951:

Anticoagulant therapy in thromboembolic disease

Krasnoperov, F.T., 1961:

Anticoagulant therapy in thrombophlebitis of the extremities

Richier, J.L.; Richier-Chevrel, M.E., 1952:

Anticoagulant therapy in venous thromboses

Gasparri, F., 1951:

Anticoagulant therapy in venous thrombosis of the retina; considerations on 15 cases

Pequignot, H.; Boyer, C.H.; Tribouil Loy, M., 1959:

Anticoagulant therapy in very old people

Maragnani, U., 1958:

Anticoagulant therapy of a case of priapism

Spittel, J.A.; Siekert, R.G., 1957:

Anticoagulant therapy of a patient with aorticarch syndrome

Villani, M., 1959:

Anticoagulant therapy of acute myocardial infarct

Lee, K.T.; O'neal, R.M., 1956:

Anticoagulant therapy of acute myocardial infarction; an evaluation from autopsy data with special reference to myocardial rupture and thromboembolic complications

Bugar-Meszaros, K.; Fono, J., 1963:

Anticoagulant therapy of arterial thrombosis and embolism in the limbs

Gordin, R., 1953:

Anticoagulant therapy of cardiac infarct

Rasmussen, H., 1952:

Anticoagulant therapy of cardiac infarction

Sturup, H.; Fog, T., 1953:

Anticoagulant therapy of cerebral apoplexy; differential diagnosis of hemorrhage and encephalomalacia

Tattoni, G.; Malchiodi, C., 1954:

Anticoagulant therapy of chronic obliterating peripheral arteriopathy

Meneghini, P.; Cataldi, R., 1953:

Anticoagulant therapy of congestive heart failure: importance of anticoagulant-mercurial combinations

Maekawa, T.; Hasegawa, T.; Ikegata, S.; Ono, H.; Ito, T., 1962:

Anticoagulant therapy of coronary artery diseases

Fujii, J.; Hosoda, S., 1962:

Anticoagulant therapy of heart disease

Loffler, W.; Schnebli, M., 1955:

Anticoagulant therapy of myocardial infarct

Lenegre, J.; Beaumont, J.L., 1952:

Anticoagulant therapy of myocardial infarct and intractable angina pectoris

Beaumont, J.L.; Maurice, P.; Chevalier, H.; Coblentz, B.; Lenegre, J., 1952:

Anticoagulant therapy of myocardial infarct; in vitro heparin tolerance test

Weber, K.; Klein, P., 1953:

Anticoagulant therapy of myocardial infarction

Askanas, Z.; Zawadzki, Z., 1950:

Anticoagulant therapy of myocardial infarction with presentation of cases

Bugar-Meszaros, K.; Praznovszky, M., 1960:

Anticoagulant therapy of myocardial infarcts and other heart diseases

Levina, I., 1958:

Anticoagulant therapy of myocardial pre-infarcts and acute infarcts

Lund, F., 1956:

Anticoagulant therapy of peripheral arterial disease

Karges, O., 1958:

Anticoagulant therapy of peripheral arterial embolism

Soulie, P.; Chiche, P.; Degeorges, M.; Acar, J., 1960 :

Anticoagulant therapy of peripheral arterial embolisms in mitral stenosis

Hynie, J.; Cermak, L.; Gregor, O.; Pokorny, J., 1952:

Anticoagulant therapy of priapism with pelentan in chronic myeloid leukemia

Burton, C.R., 1954:

Anticoagulant therapy of recent cardiac infarction

Ferrandi, X., 1951:

Anticoagulant therapy of sequels of thrombo-embolism at La Léchère

Cataldi, R., 1952:

Anticoagulant therapy of stenocardiac syndromes

Prats, F., 1958:

Anticoagulant therapy of the hypostatic syndrome of the lower extremity (leg ulcer)

Schenk, H., 1955:

Anticoagulant therapy of the myocardial infarct

Cloetens, W.; Tenzer, C.; Mascart, P., 1952:

Anticoagulant therapy of thromboembolic diseases

Remde, W., 1953:

Anticoagulant therapy of thromboembolic diseases with special reference to phenindione

Richter, W., 1953:

Anticoagulant therapy of thromboembolism

Frommeyer, W.B., 1954:

Anticoagulant therapy of thrombophlebitis

Bugar-Meszaros, K.; Fono, J., 1962:

Anticoagulant therapy of thrombosis and embolism of arteries of the extremities

Schreck, W., 1951:

Anticoagulant therapy of thrombosis and embolism with dicuman and thrombocid

Hummelt, K., 1956:

Anticoagulant therapy of thrombosis of the central retinal vein

Luk'ianenko, I.V., 1958:

Anticoagulant therapy of vascular diseases of the brain

Izar, G., 1952:

Anticoagulant therapy of venous thrombosis

Wright, I.S., 1952:

Anticoagulant therapy over a long period

Merz, W.R., 1952:

Anticoagulant therapy post-partum and postoperative of thrombosis

Alexander, B., 1962:

Anticoagulant therapy with coumarin congeners. Action and guidelines

Ericsson, E.; Korsan-Bengtsen, K., 1955:

Anticoagulant therapy with dicumarol and similar preparations

Mullertz, S.; Storm, O., 1954:

Anticoagulant therapy with dicumarol maintained during major surgery

Goodwin, J.F.; Macgregor, A.G., 1950:

Anticoagulant therapy with heparin in Pitkin's menstruum

Jorgensen, G., 1955:

Anticoagulant therapy with marcoumar; with criticism of ambulant use

Langer, H., 1954:

Anticoagulant therapy with marcumar

Buzzi, A.; Fustinoni, O.; Carbajal, B., 1959:

Anticoagulant therapy with phenylindanedione. A clinical analysis of 101 cases

Cardi, L.; Biffani, G., 1958:

Anticoagulant therapy with phenylindanedione; improved therapeutic plans; prolonged therapy

De Nicola, P.; Colli, A.; Rosti, P., 1954:

Anticoagulant therapy with preparations having prolonged dicoumarin action such as 3-(1 phenylpropyl)-4-hydroxycoumarin; antidote effect of synthetic vitamin K1

Malagamba, P.D.; De Cecco, L., 1961:

Anticoagulant therapy with rotatory and tolerance thrombelastography

Garcia Turiella, R.; Gaspary, F.V.; Tuero, P.R.; Ferrer, J., 1953:

Anticoagulant therapy with tromexan

Ferriman, D.G.; Till, E.M., 1955:

Anticoagulant therapy, determination of maintenance dosage

Lewis, J.F., 1951:

Anticoagulant therapy--a review

Renger, F.; Heine, H., 1963:

Anticoagulant therapy-practical experiences and instructions

Kupfer, H.G., 1963:

Anticoagulant therapy. I

Marple, C.D., 1956:

Anticoagulant therapy. I. Medical aspects

Kupfer, H.G., 1963:

Anticoagulant therapy. II. Dicumarol and its derivatives--indirect acting anticoagulants

Jimenez Casado, M., 1954:

Anticoagulant therapy. II. Indications, results and contraindications

Mcintyre, M.J., 1956:

Anticoagulant therapy. II. Nursing care

Gauthier, J.; Proulx, A., 1960:

Anticoagulant therapy. Its use and control

de ALMEIDA, E.; GINEFRA, P.; MONTEIRO, M.M.; RIBEIRO, C.P.; de ALMEIDA, A., 1960:

Anticoagulant therapy. Use in a new prothrombin activity range

Todd, D.W., 2003:

Anticoagulant therapy: consideration of modification in conjunction with minor surgery

Chavannaz, J.; Cluzel, P., 1957:

Anticoagulant therapy: its accidents and their prevention

Preziosi, P., 1951:

Anticoagulant therapy: present and future indications

Gonin, A.; Delahaye, J.P., 1961:

Anticoagulant therapy: rational use, abuse, complications and accidents

Rossitto, G., 1953:

Anticoagulant therapy: study of new methods in the use of heparin

Desrochers, Y.; Aerichide, N.; David, P., 1959:

Anticoagulant therapy; clinical experience with acenocoumarin (Sintrom) and other coumarin derivatives

Russek, H.I., 1955:

Anticoagulant therapy; its present status in acute myocardial infarction

Olwin, J.H.; Arscott, P.M.; Koppel, J.L., 1958:

Anticoagulant therapy; principles & practical application

Lund, E., 1952:

Anticoagulant therapy; review

Marois, A.; Brosseau, C., 1955:

Anticoagulant therapy; tromexan and G-23350

Di Cera, E., 2004:

Anticoagulant thrombins

Mouquin, M.; Sauvan, R.; Richon, J.; Samama, M.; Liozon, F.; Leborgne, P., 1960:

Anticoagulant treatment by warfarin sodium in cardiology. Apropos of 63 cases (2710 days of treatment)

Buliková, A.; Penka, M., 2006:

Anticoagulant treatment failure

Gumpert, T.E., 1962:

Anticoagulant treatment in 104 male cases of acute myocardial infarction

Edeiken, J., 1961:

Anticoagulant treatment in acute coronary occlusion with "so-called" ischemic pattern

Sanchez-Peña, P.; Lechat, P., 2003:

Anticoagulant treatment in atrial fibrillation

Sepúlveda, J.M.; Posada, I.J.; González de la Aleja, J.; Ramos, A.; Bermejo, F., 2004:

Anticoagulant treatment in hemorrhagic brains infarts due to large sinus venous thrombosis

Heichmann, J., 1955:

Anticoagulant treatment in myocardial infarction

Nilsson, G.H.; Björholt, I.; Johnsson, H., 2003:

Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered population

Carter, A.B., 1961:

Anticoagulant treatment in progressing stroke

Castro, H.; Corvalan, H.; Villagra, R., 1960:

Anticoagulant treatment in thrombophlebitis. Importance of the Coagulation Department

Hilden, T.; Iversen, K.; Raaschou, F.; Schwartz, M., 1961:

Anticoagulant treatment of acute cardiac infarction

Hansen, O.E.; Lund, M., 1962:

Anticoagulant treatment of acute cerebral infarct, with special reference to the prevention of extracerebral thromboembolic complications

Frileux, C.; Sakka, M., 1958:

Anticoagulant treatment of arterial diseases of the extremities

Froment, R., 1962:

Anticoagulant treatment of cardiovascular diseases of ischemic origin

Closges, J.; Norpoth, L., 1957:

Anticoagulant treatment of cardiovascular diseases; experiences with a new oxycoumarin derivative

Dalsgaard-Nielsen, T.; Skinhoj, E., 1957:

Anticoagulant treatment of cerebral thrombosis

Debenedetti, V.; Ravera, M., 1959:

Anticoagulant treatment of cerebral vascular accidents

Weithaler, K.; Tuba, J., 1957:

Anticoagulant treatment of chronic cor pulmonale

De Nicola, P.; Tartara, A., 1956:

Anticoagulant treatment of coronary occlusion; comparative study of 37 treated and 66 non-treated cases

Loffler, W., 1957:

Anticoagulant treatment of myocardial infarct

Wilcken, D.E.; Mackenzie, K.M.; Goodwin, J.F., 1960:

Anticoagulant treatment of obliterative pulmonary hypertension

Nilsson, G.H.; Björholt, I.; Krakau, I., 2004:

Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden--a retrospective study of incidence and quality in a registered population

Blum, M., 1957:

Anticoagulant treatment of phlebothrombosis during pregnancy

Alonzo, M., 1958:

Anticoagulant treatment of postoperative venous complications

Pinède, L.; Ninet, J., 2003:

Anticoagulant treatment of thrombo-embolic venous disease

Flessinger, J-Noël., 2006:

Anticoagulant treatment of thromboses, a long term treatment

Welti, J.J., 1962:

Anticoagulant treatment of venous thromboses

Izarn, P., 1954:

Anticoagulant treatment of venous thrombosis

Plesch, S.A.; Cosentino, J.J.; Etcheves, J.C., 1962:

Anticoagulant treatment with sodium warfarin

Beaumont, J.L., 1960:

Anticoagulant treatment. Theory and practice

Patel, P.; Suneja, A., 2005:

Anticoagulant use for atrial fibrillation in older people

Grand'Maison, A.; Charest, A.F.; Geerts, W.H., 2005:

Anticoagulant use in patients with chronic renal impairment

Hamrick, I., 2003:

Anticoagulant use in patients with risk of falling

Ishikawa, K., 2003:

Anticoagulant, antiplatelet agents

Frank, R.Dario.; Müller, U.; Lanzmich, R.; Groeger, C.; Floege, Jürgen., 2005:

Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits

Polat, C.; Dervisoglu, A.; Guven, H.; Kaya, E.; Malazgirt, Z.; Danaci, M.; Ozkan, K., 2003:

Anticoagulant-induced intramural intestinal hematoma

Beitz, J.M., 2004:

Anticoagulant-induced skin necrosis

Meneghini, P.; Cataldi, R., 1953:

Anticoagulant-mercurial association in the therapy of congestive decompensation of the heart

Pechlaner, C., 2004:

Anticoagulant-related bleeding risk in older persons: unfounded fears?

Jörg, I.; Fenyvesi, T.; Harenberg, J., 2003:

Anticoagulant-related skin reactions

Chaudhry, S.I.; George, M.L.; Madans, B.; Black, M.M., 2005:

Anticoagulant-responsive pyoderma gangrenosum associated with an underlying prothrombotic dysfibrinogenaemia

Riggs, D.S., 1950:

Chazov, E.I., 1958:

Anticoagulants (heparin) in prevention and theraly of thromboembolic complications of myocardial infarction

Rice-Wray, E., 1964:

Anticoagulants After Myocardial Infarction

Planas, J., 1963:

Anticoagulants and Evaluation of Serum Iron

Smith, B.; Umapathy, A.; Bentall, H.H.; Cleland, W.P., 1965:

Anticoagulants and Mitral Valvotomy

Bocquet, L., 1964:

Anticoagulants and Pregnancy. Hazards for the Infant

Shaw, D.A., 1965:

Anticoagulants and the Completed Stroke

Owren, P.A., 1964:

Anticoagulants and their Control in the Surgical Patient

Hicks, H.E., 1965:

Anticoagulants for Cerebral Arteriosclerosis

Stewart, I.M., 1964:

Anticoagulants for Strokes

Sturm, E., 1964:

Anticoagulants in Ambulatory Practice

Sveshnikov, A.I., 1964:

Anticoagulants in Embolism of the Aortic Bifurcation

Mcdonald, G.L., 1963:

Anticoagulants in Myocardial Infarction

Deutsch, E., 1964:

Anticoagulants in the Therapy of Peripheral Arterial Circulation Disorders

Zambrano, A., 1963:

Anticoagulants in the Treatment and Prevention of Coronary Diseases

Riosmozo, M.; Zamoramadaria, E., 1963:

Anticoagulants in the Treatment and Prophylaxis of Pulmonary Embolism

Artemkina, N.I., 1964:

Anticoagulants in the Treatment of Mesenterial Thromboembolism

Doichinov, A., 1963:

Anticoagulants in the Treatment of Myocardial Infarct

Meyer, J.S.; Gilroy, J.; Barnhart, M.I.; Johnson, J.F., 1964:

Anticoagulants Plus Streptokinase Therapy in Progressive Stroke

Brown, A.; Douglas, A.S., 1952:

Anticoagulants and anticoagulant therapy; a review

Bath, P., 2003:

Anticoagulants and antiplatelet agents in acute ischaemic stroke

Tsakiris, D.A., 2005:

Anticoagulants and antiplatelet agents in pregnancy

Ball, K., 1955:

Anticoagulants and arteriosclerosis

Rasekh, A., 2005:

Anticoagulants and atrial fibrillation

Dotzauer, G., 1958:

Anticoagulants and blood group reactions

Schanbacher, C.F., 2004:

Anticoagulants and blood thinners during cutaneous surgery: always, sometimes or never?

Jornayvaz, F.R.; Perrier, A., 2006:

Anticoagulants and cancer: beyond thromboembolic disease prevention

Himbert, J., 1952:

Anticoagulants and cation exchange resins

Gaudy, J.F.; Ankri, A.; Tager, F.; El Haddioui, A.; Bravetti, P.; Lafont, A.; Gogly, B., 2005:

Anticoagulants and dental extractions

Von Kaulla, K.N., 1953:

Anticoagulants and fibrinolysis

Crowther, M.; Adams, P., 2005:

Anticoagulants and gastrointestinal bleeding

Descuns, P.; Garre, H.; Ramee, A.; Thevenot, C., 1961:

Anticoagulants and neurosurgery

Pratt, G.H., 1953:

Anticoagulants and sympathetic nerve blocks in the treatment of vascular lesions; effective therapeutic combination

Agostino, D.; Cliffton, E.E., 1962:

Anticoagulants and the development of pulmonary metastases. Anticoagulant effect on the Walker 256 carcinosarcoma in rats

Toro, G.Yco, E.; Rivera, C.Llazo, E., 1962:

Anticoagulants and the uptake of L-triiodothyronine by rat erythrocytes

Diaz De Yraola, G.; Martin Garcia, E., 1963:

Anticoagulants and their methods of action. The laboratory in the control of such drugs

Schulman, S.; Bijsterveld, N.R., 2006:

Anticoagulants and their reversal

Jordan, F.L.J., 1950:

Anticoagulants and their use

Krupnikova, E.Z., 1959:

Anticoagulants and their use in coronary disorders; review of the literature

Morhardt, P.E., 1953:

Anticoagulants and thromboembolism

Arora, N.; Goldhaber, S.Z., 2006:

Anticoagulants and transaminase elevation

Aguirre, J.R.; Boher, R.O., 1958:

Anticoagulants as preventives of lesions induced by irradiation of the nervous system

Gubitz, G.; Sandercock, P.; Counsell, C., 2004:

Anticoagulants for acute ischaemic stroke

Blake, T.M., 1963:

Anticoagulants for acute myocardial infarction. A discussion of the problem

Cundiff, D.K., 2003:

Anticoagulants for nonvalvular atrial fibrillation (NVAF)--drug review

García-Lizana, F.R.; Sarría-Santamera, A.; Gol-Freixa, J., 2004:

Anticoagulants for patients with chronic auricular fibrillation: when are they indicated?

Saxena, R.; Koudstaal, P.J., 2004:

Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack

Mohr, J.P., 2003:

Anticoagulants for prevention of ischemic stroke: current concepts

Di Nisio, M.; Peters, L.; Middeldorp, S., 2005:

Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome

Freeman, I.; Wexler, J., 1963:

Anticoagulants for treatment of atrial fibrillation

Richards, R.L., 1962:

Anticoagulants in acute myocardial infarction. A clinicopathological study

Chalfin, M.H.; Lundberg, G.A., 1956:

Anticoagulants in acute myocardial infarction; a review of the literature and the experiences at the Hartford Hospital

Fabre, J., 1953:

Anticoagulants in cardiology

Borg, J.F., 1952:

Anticoagulants in cardiovascular disease

Macias Castro, I., 1958:

Anticoagulants in cerebrovascular accidents

Sabatini, R.; Puech, P., 1961:

Anticoagulants in children

De Nicola, P., 1963:

Anticoagulants in clinical medicine

Maurizio, E., 1957:

Anticoagulants in clinical obstetrics & gynecology

Gilchrist, A.R., 1954:

Anticoagulants in coronary occlusion

Rytand, D.A., 1951:

Anticoagulants in coronary thrombosis with myocardial infarction

Manguel, M.; Pisarevsky, J.; Torrea, N., 1962:

Anticoagulants in daily practice and our experience with Sintrom

Robertson, K., 1954:

Anticoagulants in domiciliary practice

Elo, J.; Estola, E.; Malmstrom, N., 1953:

Anticoagulants in fungi

Mosso, H.E.; Campos, A.; Pergola, F., 1961:

Anticoagulants in geriatrics

Koller, F., 1962:

Anticoagulants in heart diseases

Wauer, D., 1951:

Anticoagulants in high-seated arterial embolism

Avellaneda, M., 1956:

Anticoagulants in myocardial infarct & angina pectoris

Schmidt-Elmendorff, H., 1954:

Anticoagulants in myocardial infarct after coronary thrombosis

Brotman, I., 1958:

Anticoagulants in myocardial infarction acute and long-term therapy

Graves, S., 1956:

Anticoagulants in myocardial infarctions

Faber, J.E.; Kvale, W.F., 1955:

Anticoagulants in obstetrics

Coolidge, C.W.; Torpin, R., 1951:

Anticoagulants in obstetrics, with a case report

Dorello, U., 1958:

Anticoagulants in ophthalmology

James, A.H.; Abel, D.E.; Brancazio, L.R., 2005:

Anticoagulants in pregnancy

Greer, I.A., 2006:

Anticoagulants in pregnancy

Favre-Gilly, J.; Ithier, S.; Blanc, R.; Borel-Milhet, M.F.; Croizat, P.; Froment, R., 1953:

Anticoagulants in prevention and treatment of postoperative vascular complications

McCOOK, J.; MILANES, B.; TOLEDO, F.; CASTILLO, F.; CARRILLO, P.; PEREZ, M.; UGUET, E., 1957:

Anticoagulants in reconstructive vascular surgery

Frileux, C., 1950:

Anticoagulants in surgery

Norwich, I., 1950:

Anticoagulants in surgery; the clinical application

Rose, W.M., 1950:

Anticoagulants in the management of cardiac infarction: a pathological and clinical study

ROSE, W.McI., 1950:

Anticoagulants in the management of cerebral infarction; a record of the poor result obtained

Jurgens, J., 1950:

Anticoagulants in the management of vascular diseases

Gordonoff, T., 1958:

Anticoagulants in the prevention & therapy of thrombo-embolic diseases; report of an inquiry

Voznesenskii, N.L., 1958:

Anticoagulants in the prevention and therapy of otogenic sinus thrombosis

Favre-Gilly, M.J.; Ithier, S.; Blanc, M.R.; Borel-Milhet, M.F.; Croizat, P.; Froment, R., 1953:

Anticoagulants in the prevention and treatment of postoperative venous complications

Lefebvre, C.; Tapie, J.; Monnier, J.; Poulhes, J.; Lareng, L.; Sarrazin, 1958:

Anticoagulants in the preventive & curative treatment of hyperthermias following splenectomy

Jimenez-Castellonos, J.; Calvo-Rubio, 1963:

Anticoagulants in the treatment and prevention of cerebrovascular accidents

Weiss, M.M., 1954:

Anticoagulants in the treatment of acute myocardial infarction:analysis of 115 attacks

Raynaud, R.; D'eshougues, J.R.; Nakache, G., 1955:

Anticoagulants in the treatment of atherosclerosis

Kerwin, A.J., 1953:

Anticoagulants in the treatment of cardiac infarction

Celice, J.; Plas, F.; Tournilhac, M., 1954:

Anticoagulants in the treatment of cardiac insufficiency in chronic lung diseases

Antic, R.S., 1957:

Anticoagulants in the treatment of cardiovascular diseases

Boudin, G.; Barbizet, J.; Labram, C., 1960:

Anticoagulants in the treatment of cerebral softening

McDEVITT, E.; FOLEY, W.T.; WRIGHT, I.S., 1954:

Anticoagulants in the treatment of cerebral thrombosis and embolism

Nederburgh, C.W., 1960:

Anticoagulants in the treatment of cerebrovascular occlusion in or after its acute phase

Holten, C., 1950:

Anticoagulants in the treatment of coronary occlusion

Holten, C., 1951:

Anticoagulants in the treatment of coronary thrombosis

Mendez, L.; Zajarias, S.; Delgado, A., 1951:

Anticoagulants in the treatment of myocardial infarction

Thorne, B.T., 1961 :

Anticoagulants in the treatment of retinal vein thrombosis

Meyer, P., 1961:

Anticoagulants in the treatment of thromboembolic complications

Merz, W.R., 1950:

Anticoagulants in the treatment of thrombosis and pulmonary embolism

Rouillard, J.M., 1953:

Anticoagulants in therapy of myocardial infarct

Carli, A.; Fornasari, P., 1954:

Anticoagulants in therapy of thromboembolic cerebral accidents

Seidler, M.; Zajac, F., 1952:

Anticoagulants in therapy of thromboses and infarcts

Dardi, M., 1951:

Anticoagulants in therapy; clinical contribution

Avellaneda, M., 1956:

Anticoagulants in thrombophlebitis & arteriosclerosis obliterans

Zeluff, G.W.; Field, W.W., 1950:

Anticoagulants in treatment of coronary occlusion with myocardial infarction; a study of 8 cases

Tulloch, J.A.; Gilchrist, A.R., 1950:

Anticoagulants in treatment of coronary thrombosis

Soulie, P.; Chiche, P., 1962:

Anticoagulants in valvular heart diseases

Riddell, D.H., 1957:

Anticoagulants in venous thrombosis of lower extremities

Chevallier, P.; Fiehrer, A., 1956:

Anticoagulants of the blood plasma

Mentzer, C., 1955:

Anticoagulants of the coumarin type; historical outline

Neuman, M., 1959:

Anticoagulants of the dicumarol type

Caplan, L.R., 2006:

Anticoagulants to prevent stroke occurrence and worsening

de CASTRO, P., 1962:

Anticoagulants used in clinical practice. Mechanism of action

Saxena, R.; Koudstaal, P., 2004:

Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack

Cundiff, D.K.; Manyemba, J.; Pezzullo, J.C., 2006:

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Ciocia, D.; Gatteschi, M., 1954:

Anticoagulants, prothrombinemia and fibrinogenemia

Kupfer, H.G.; Kinne, D.R., 1958:

Anticoagulants, theoretical considerations and laboratory control

Jaques, L.B., 1962 :

Anticoagulants, thrombosis and hemorrhage

Satake, K.; Watanuki, M.; Banjaku, H.; Nakata, H.; Mibukura, Y.; Ichikawa, A., 1963:

Anticoagulants--on a few problems

Haas, S., 2004:

Anticoagulants--well tried and new. Medical prevention and treatment of thromboembolism

Reppel, L., 1963:

Anticoagulants. 1. Blood Coagulation and its Modification by Coumarins and Indandiones

Reppel, L., 1964:

Anticoagulants. 2. Heparins, Haparinoids, Rare Earths and Thrombolytics

De Rosnay, C.D., 1956:

Anticoagulants. I. Direct anticoagulants: heparin and heparin-like drugs

De Rosnay, C.D., 1956:

Anticoagulants. II. Indirect anticoagulants with prothrombinopenic action; dicumarol derivatives and synthetic anticoagulants

Anonymous, 2004:

Anticoagulants. Oral drug options may expand

Schmitt-Hönl, B., 2006:

Anticoagulants. Self management is safer

Mcmichael, J., 1964:

Anticoagulants: Another View

Mason, W.E., 2005:

Anticoagulants: another option

Armas-Cruz, R.; Lobo-Parga, G.; Davila, M., 1952:

Anticoagulants; preliminary communication

Velarde-Frias, R.; Shaffer, M.F., 1964:

Anticoagulase in Sera of Children with Staphylococcal Infections

Todd, D.W., 2003:

Anticoagulated patients and oral surgery

Marty, T.; Hurni, R.; Zoller, M.; Steiger, U.; Steurer, J.; Eichler, K., 2003:

Anticoagulatin in atrial fibrillation--status of therapy in a network of physicians

Naso, A.; Marcacci, M., 1953:

Anticoagulating effect of sulfonamides on blood in vitro

Dekhtiar, A.L., 1963:

Anticoagulation Activity of Heparin in the Blood of Patients with Obliterating Atherosclerosis of the Blood Vessels of the Lower Extremities

Agarwal, S.C.; Sibal, L.; Pepper, C.B., 2005:

Anticoagulation after cardioversion in atrial fibrillation: how long should we warfarinise for?

Faust, F.B., 1953:

Anticoagulation and alphatocopherol

Biasiutti, F.Demarmels.; Strebel, J.Kremer.Hovinga., 2003:

Anticoagulation and antiaggregation during pregnancy

Meyer, B.J., 2003:

Anticoagulation and antiaggregation in cardiac patients

Arnold, M.; Nedeltchev, K.; Mattle, H.P., 2003:

Anticoagulation and antiaggregation in neurological patients

Dörffler-Melly, J.; Schmidli, J.; Mahler, F., 2003:

Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases

Kühne, T., 2003:

Anticoagulation and antiaggregation in pediatrics

Amanzadeh, J.; Reilly, R.F., 2006:

Anticoagulation and continuous renal replacement therapy

Koller, F., 1960:

Anticoagulation and heart infarct

Hughes, C.F., 2005:

Anticoagulation and mechanical heart valves: extrapolation has its hazards

Bergqvist, D.; Wu, C.L.; Neal, J.M., 2003:

Anticoagulation and neuraxial regional anesthesia: perspectives

Gammelgaard, P.A.; Mathiesen, F., 1962:

Anticoagulation and operation

Baird, C.W.; Zurakowski, D.; Robinson, B.; Gandhi, S.; Burdis-Koch, L.; Tamblyn, J.; Munoz, R.; Fortich, K.; Pigula, F.A., 2007:

Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival

Chong, J.Y.; Mohr, J.P., 2005:

Anticoagulation and platelet antiaggregation therapy in stroke prevention

Jaimes, Fán.; de la Rosa, G., 2006:

Anticoagulation and sepsis: the opportunity for a new use of heparin?

Bloom, D.C.; Haegen, T.; Keefe, M.A., 2003:

Anticoagulation and spontaneous retropharyngeal hematoma

Lawrence, P.F., 1982:

Anticoagulation and temporary graft occlusion to determine the need for revascularization following vascular graft infection

Rincon, F., 2004:

Anticoagulation and thrombolysis for acute ischemic stroke and the role of diagnostic magnetic resonance imaging

Bidstrup, B., 2005:

Anticoagulation and transfusion management in cardiac surgery

Lane, D.A.; Lip, G.Yh., 2005:

Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification

Wenger, N.K.; Scheidt, S.; Weber, M.A., 2003:

Anticoagulation at elderly age: the challenge to do better

Isma'eel, H.; Zebian, R.; El-Accaoui, R.; Dimassi, A.; Rashid, K.; Alam, S.; Taher, A.; Khoury, M.; Arnaout, M.Samir., 2006:

Anticoagulation clinics are needed in developing countries

Du, X.; Ma, C-sheng.; Liu, X-hui.; Dong, J-zeng.; Wang, J-nan.; Cheng, X-jing., 2005:

Anticoagulation control in atrial fibrillation patients present to outpatient clinic of cardiology versus anticoagulant clinics

Lane, D.A.; Boos, C.J.; Lip, G.Y.H., 2006:

Anticoagulation control with vitamin K antagonists: how well are we doing?

Stellbrink, C.; Schimpf, T., 2005:

Anticoagulation during cardioversion in patients with atrial fibrillation: current clinical practice

Kim, Y-Goo., 2004:

Anticoagulation during haemodialysis in patients at high-risk of bleeding

Halperin, J.L., 2005:

Anticoagulation for atrial fibrillation in the elderly

Mesas, Cézar.E.; Veloso, H.H.; De Paola, A.A.V., 2004:

Anticoagulation for atrial fibrillation: underutilization in a Brazilian tertiary outpatient clinic

Warkentin, T.E., 2006:

Anticoagulation for cardiopulmonary bypass: is a replacement for heparin on the horizon?

Levy, I.; Berg, L.; Harkin, J.A., 1957:

Anticoagulation for cerebrovascular insufficiency; post-mortem examination of patients who died of other causes

Perloff, J., 2003:

Anticoagulation for mechanical valve protheses during pregnancy

Boos, C.J.; More, R.S., 2004:

Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatran

Amemiya, H.; Sekihara, H.; Kobayashi, T.; Koiwa, F.; Niikura, K., 2004:

Anticoagulation for plasmapheresis

Weil, J.; Schunkert, H., 2005:

Anticoagulation for secondary prevention: which drug in which situation?

Elkind, M.S.V., 2007:

Anticoagulation for secondary stroke prevention: another nail in the coffin?

Gross, B.; Lampl, Y., 2006:

Anticoagulation for stroke prevention

Lip, G.Y.H.; Watson, T.; Shantsila, E., 2006:

Anticoagulation for stroke prevention in atrial fibrillation: is gender important?

Shantsila, E.; Watson, T.; Lip, G.Y.H., 2006:

Anticoagulation for stroke prevention: high effectiveness, more cost benefit?

Mohr, J.P., 2004:

Anticoagulation for stroke prevention: yes, no, maybe

Jacobson, B., 2006:

Anticoagulation in South Africa--a dangerous necessity

Ibrahim, A.; Ashkan, K.; Smith, M.; Watkins, L., 2003:

Anticoagulation in a head-injured patient

Scholten, M.F.; Thornton, A.S.; Mekel, J.M.; Koudstaal, P.J.; Jordaens, L.J., 2005:

Anticoagulation in atrial fibrillation and flutter

Cruz, I.; Sánchez-Ledesma, Mía.; Puerto, E.; Sánchez-Rodríguez, A., 2005:

Anticoagulation in atrial fibrillation, do we achieve the recommendations?

Anonymous, 2004:

Anticoagulation in atrial fibrillation. Instead of costly therapy control soon a tablet for all?

Putnam, W.; Nicol, K.; Anderson, D.; Brownell, B.; Chiasson, M.; Burge, F.I.; Flowerdew, G.; Cox, J., 2004:

Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients?

Wyse, D.George., 2007:

Anticoagulation in atrial fibrillation: a contemporary viewpoint

Dharmarajan, T.S.; Lebelt, A.S.; Norkus, E.P., 2006:

Anticoagulation in atrial fibrillation: what decides? Patient status, provider opinion, or both?

Schimpf, T.; Stellbrink, C., 2003:

Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future

Zhuang, W.; Zhou, X-Min.; Hu, J-Guo.; Li, J-Min.; Yu, J-Feng.; Jiang, L.; Hu, D-Xu., 2005:

Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves

Cappuzzo, K.A., 2006:

Anticoagulation in elderly patients who fall frequently: a therapeutic dilemma

Black, J.M., 2004:

Anticoagulation in elective surgery

Ghosh, K.; Shetty, S., 2004:

Anticoagulation in haemophilia patients with prosthetic valve replacement

De Cristofaro, R., 2006:

Anticoagulation in ischaemic heart disease

van Gijn, J.; Algra, A., 2005:

Anticoagulation in ischemic stroke: opportunities in arterial disease

Fraser, M.; Nutescu, E.; Jacobs, L.G., 2003:

Anticoagulation in long-term care: the state of the art

Veloso, H.H.; de Paola, A.A.V., 2005:

Anticoagulation in patients with atrial fibrillation and congestive heart failure

Paparella, D.; d'Agostino, C.; Schinosa, L.de.Luca.Tupputi., 2004:

Anticoagulation in patients with cardiac valve prostheses

Niksic, L.; Saudan, P.; Boehlen, F., 2006:

Anticoagulation in patients with chronic renal failure

Geelani, M.A.; Singh, S.; Verma, A.; Nagesh, A.; Betigeri, V.; Nigam, M., 2005:

Anticoagulation in patients with mechanical valves during pregnancy

Currie, C.J.; McEwan, P.; Emmas, C.; Morgan, C.Ll.; Peters, J.R., 2005:

Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population

Rüfer, A.; Wuillemin, W.A., 2003:

Anticoagulation in patients with venous thromboembolism

Copplestone, J.Adrian.; Pavord, S.; Hunt, B.J., 2003:

Anticoagulation in pregnancy: a survey of current practice

Marcus-Braun, N.; Segal, D.; Merkin, M.; Wiznitzer, A.; Katz, M.; Tager, S.; Ilya, R.; Mazor, M., 2003:

Anticoagulation in pregnant women with prosthetic heart valve--a new approach for therapy

Agarwal, R.; Gupta, D., 2005:

Anticoagulation in sepsis: is low-dose heparin as effective as activated protein C?

Michota, F.; Merli, G., 2005:

Anticoagulation in special patient populations: are special dosing considerations required?

Casais, P.; Alberto, Mía.F.; Gennari, L.C.; Grosso, S.H.; Meschengieser, S.S.; Lazzari, Mía.A., 2004:

Anticoagulation in the antiphospholipid syndrome

Kandzari, D.E., 2007:

Anticoagulation in the cath lab: a contemporary approach. Introduction

Monagle, P., 2004:

Anticoagulation in the young

Head, D.; Pierce, B., 2005:

Anticoagulation in urban family practice training

Vemmos, K.N.; Tsivgoulis, G.; Spengos, K.; Manios, E.; Toumanidis, S.; Zakopoulos, N.; Moulopoulos, S.D., 2005:

Anticoagulation influences long-term outcome in patients with nonvalvular atrial fibrillation and severe ischemic stroke

Hart, R.G., 2006:

Anticoagulation intensity and stroke during warfarin-use in atrial fibrillation patients

Ezekowitz, M.D., 2004:

Anticoagulation interruptus: not without risk

Cothren, C.Clay.; Moore, E.E.; Biffl, W.L.; Ciesla, D.J.; Ray, C.E.; Johnson, J.L.; Moore, J.B.; Burch, J.M., 2004:

Anticoagulation is the gold standard therapy for blunt carotid injuries to reduce stroke rate

Riess, F-Christian., 2005:

Anticoagulation management and cardiac surgery in patients with heparin-induced thrombocytopenia

Charbucinska, K.Natasza.; Godet, G.; Itani, O.; Fleron, M-Hélène.; Bertrand, Mèle.; Rienzo, M.; Coriat, P., 2006:

Anticoagulation management for patients with drug-eluting stents undergoing vascular surgery

Al-Rashid, M.; Parker, M.J., 2005:

Anticoagulation management in hip fracture patients on warfarin

Tharmarajah, P., 2006:

Anticoagulation management in hip fracture patients on warfarin [Injury 2005;36:1311-5

Johnson, J.T.; Granberry, M.C.; Thomas, A.R.; Smith, E.S., 2003:

Anticoagulation management in mechanical heart valve patients who undergo dental procedures

Pappalardo, F.; Franco, A.; Crescenzi, G.; De Simone, F.; Torracca, L.; Zangrillo, A., 2007:

Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration

Nast, S.L.; Tierney, M.J.; McIlwain, R., 2006:

Anticoagulation management in remote primary care

Jaffer, A.K., 2006:

Anticoagulation management strategies for patients on warfarin who need surgery

Wurster, M.; Doran, T., 2006:

Anticoagulation management: a new approach

Tremey, B.; Szekely, B.; Schlumberger, S.; François, D.; Liu, N.; Sievert, K.; Fischler, M., 2006:

Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR)

Schaller, B.; Lyrer, P., 2003:

Anticoagulation of an unruptured, thrombosed giant intracranial aneurysm without hemorrhage or recanalization in the long-term follow-up

Abdelhafiz, A.H.; Wheeldon, N.M., 2006:

Anticoagulation of atrial fibrillation in older people: a clinical practice observational study

Mariano, F.; Triolo, G., 2007:

Anticoagulation of extracorporeal circuit in critically ill patients

Koster, A.; Kukucka, M., 2006:

Anticoagulation of patients with heparin-induced thrombocytopenia in cardiac surgery

Bauersachs, R.; Lindhoff-Last, E., 2003:

Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin

Hanania, G.; Maroni, J.P.; el Hajj, Y., 2004:

Anticoagulation of valvular prostheses

Davenport, A., 2006:

Anticoagulation options for intermittent haemodialysis

Colli, A.; Verhoye, J-Philippe.; Leguerrier, A.; Gherli, T., 2007:

Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue

Sanford, M.F.; Moazzam, N.; Lang, D.W.; Hanley, J.F.; Potti, A., 2003:

Anticoagulation patterns and clinical decision-making following an intermediate ventilation-perfusion scan in pulmonary thromboembolism

Lip, G.Y.H.; Varma, C., 2005:

Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?

Nagra, A.; Trompeter, R.S., 2006:

Anticoagulation post-renal transplant: is it indicated?

Shea, J.B., 2006:

Anticoagulation practice in cardiac electrophysiology

Talwar, S.; Kapoor, C.Kanta.; Velayoudam, D.; Kumar, A.Sampath., 2004:

Anticoagulation protocol and early prosthetic valve thrombosis

Zangari, M., 2006:

Anticoagulation regimens for thalidomide and lenalidomide

Pence, C.; McErlane, K., 2005:

Anticoagulation self-monitoring

Oudemans-van Straaten, H.M.; Wester, J.P.J.; de Pont, A.C.J.M.; Schetz, M.R.C., 2006:

Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Geschwinder, R.Francis., 2004:

Anticoagulation therapy a success with patient-focused model

White, R.H., 2006:

Anticoagulation therapy after recent bleeding: is it ever safe?

Tjønnfjord, G.E., 2005:

Anticoagulation therapy and oral surgery

Gamarel, K.E.; Nelson, K.M.; Stephenson, R.; Santiago Rivera, O.J.; Chiaramonte, D.; Miller, R.Lin., 2017:

Anticipated HIV Stigma and Delays in Regular HIV Testing Behaviors Among Sexually-Active Young Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women

Thorsen, R.K., 1957:

Anticoagulation therapy for congestive heart failure

Ashraf, H., 2005:

Anticoagulation therapy for stroke

Colì, L.; Donati, G.; Cianciolo, G.; Raimondi, C.; Comai, G.; Panicali, L.; Nastasi, V.; Cannarile, D.C.; Gozzetti, F.; Piccari, M.; Stefoni, S., 2006:

Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis

Cundiff, D.K., 2004:

Anticoagulation therapy for venous thromboembolism

Groedel, F.M., 1951:

Anticoagulation therapy in heart diseases

Jiang, C-yang.; Zhao, L-li.; Wang, J-an.; Mohammod, B., 2003:

Anticoagulation therapy in intra-aortic balloon counterpulsation: does IABP really need anti-coagulation?

Askari, M.; Fisher, C.; Weniger, F.G.; Bidic, S.; Lee, W.P.Andrew., 2006:

Anticoagulation therapy in microsurgery: a review

McCARTHY, A.M., 1959:

Anticoagulation therapy in obstetrics and gynecology

Risøe, C.; Gjesdal, K., 2004:

Anticoagulation therapy in paroxysmal atrial fibrillation

Harley, C.R.; Riedel, A.A.; Hauch, O.; Nelson, M.; Wygant, G.; Reynolds, M., 2005:

Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis

Ng, H.Joo.; Crowther, M.A., 2005:

Anticoagulation therapy in the antiphospholipid syndrome: recent advances

Mead, A.W.; Wright, I.S., 1961:

Anticoagulation therapy today

Lablanche, J.M., 2006:

Anticoagulation therapy: a stage in the history of percutaneous coronary intervention

Fuller, R., 2004:

Anticoagulation to prevent strokes in older people with atrial fibrillation: assembling individualized risk and benefit information

McBride, D.; Brüggenjürgen, B.; Roll, S.; Willich, S.N., 2007:

Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice

Mortensen, V.; Holten, C., 1956:

Anticoagulation treatment in acute coronary occlusion and permanent anticoagulation treatment

Freestone, B.; Lip, G.Y.H., 2003:

Anticoagulation uptake in emergency department patients with atrial fibrillation

Hartmann, A., 2006:

Anticoagulation using low-molecular-weight heparin--interview with Regina Burian

Koster, A.; Buz, S.; Hetzer, R.; Kuppe, H.; Breddin, K.; Harder, S., 2006:

Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trial

Zellerhoff, S.; Goette, A.; Kirchhof, P., 2006:

Anticoagulation with atrial fibrillation

Muñoz Morente, A.; Barón Ramos, M.A.; Mateos Fernández, S.; López Palmero, S.; Villar Jiménez, J.; Regueira Iglesias, J.M., 2004:

Anticoagulation with bemiparina after intracerebral hemorrhage as complication of bacterial endocarditis on metallic prosthetic valve

Vasquez, J.C.; Vichiendilokkul, A.; Mahmood, S.; Baciewicz, F.A., 2003:

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery

Stella, J.F.; Stella, R.E.; Iaffaldano, R.A.; Stella, D.J.; Erickson, K.W.; Bliley, R.C., 2004:

Anticoagulation with bivalirudin during percutaneous coronary intervention for ST-segment elevation myocardial infarction

Smedira, N.G.; Dyke, C.M.; Koster, A.; Jurmann, M.; Bhatia, D.S.; Hu, T.; McCarthy, H.L.; Lincoff, A.Michael.; Spiess, B.D.; Aronson, S., 2006:

Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study

Bechtold, H.; Janssen, D., 2004:

Anticoagulation with low-molecular-weight heparin in patients with heart diseases

Topol, E.J., 2003:

Anticoagulation with prosthetic cardiac valves

Bechtold, H.; Gunzenhauser, D.; Sawitzki, H.; Fung, S.; Janssen, D., 2003:

Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion

Maclean, P.S.; Tait, R.C.; Rumley, A.; McMahon, A.D.; Lowe, G.D., 2003:

Anticoagulation with warfarin downregulates inflammation

Avila, W.Samuel.; Grinberg, M., 2005:

Anticoagulation, pregnancy and cardiopathy. A triad, three dominions and five moments

Steinbigler, P.; Haberl, R., 2003:

Anticoagulation--control of heart rate--cardioversion. Therpeutic algorithm in ventricular tachycardia

Weinstein, A., 1961:

Anticoagulation--how long?

Kasper, G.C.; Welling, R.E., 2005:

Anticoagulation: The rest of the story

Olshansky, B., 2005:

Anticoagulation: new challenges, old drugs

Fojtík, Z., 2006:

Anticoagulative therapy and antiphospholipid syndrome

Schlote, T.; Freudenthaler, N.; Gelisken, F., 2004:

Anticoagulative therapy in patients with exudative age-related macular degeneration: acute angle closure glaucoma after massive intraocular hemorrhage

Sato, H.; Nitanai, A.; Kurosawa, T.; Oikawa, S., 2005:

Anticoccidial efficacy of medium-chain triglycerides (MCT) in calves

García Callejo, F.J.; Velert Vila, M.M.; Laporta, P.; Orts Alborch, M.H.; de Paula Vernetta, C.; Marco Algarra, J., 2005:

Anticochlear antibodies titles measured by Western-blot and hearing recovery level after corticoid therapy in patients with sudden deafness

Basto, E.L.; Cordeiro, A., 1957:

Anticogulant therapy in surgery of mitral stenosis

Roskam, J.; Hugues, J.; Bounameaux, Y.; Deleixhe, A., 1958:

Anticogulant therapy of cardiovascular diseases

Bryant, J., 1962:

Anticoincidence counting method for standardizing radioactive materials

Quinchon, C.; Henry, G.; Carles, R., 1961:

Anticolibacillary colostral immunity in the cow

Sieburth, J.M.; Prat, D.M., 1962:

Anticoliform activity of sea water associated with the termination of Skeletonema costatum blooms

Widholm, O.; Pohjola, R., 1955:

Anticolihemolysin (ACL) antistaphylolysin (ASTA) and antistreptolysin (AST) reactions in urologic infections

Sonck, C.E.; Widholm, O., 1954:

Anticolilysin in blood in skin diseases

Stratton, F.; Gunson, H.H., 1963:

Anticomplement (anti-C') antiglobulin reagents

Schierz, G., 1964:

Anticomplement Effects of Serum and Gamma-Globulin

Mucaji, P.; Bukovský, M.; Grancai, D.; Nagy, M., 2003:

Anticomplement activity of saponins from Cynara cardunculus L

Corbetta, L., 1962:

Anticomplement activity of the serum of subjects with nasal ozena

Cacciola, E.; Cordaro, S., 1957:

Anticomplement power of heparin

Muschel, L.H.; Schmoker, K.; Webb, P.M., 1964:

Anticomplementary Action of Endotoxin

Copyright © 2019 · All Rights Reserved
· · 浙ICP备10204677号-1